Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3019050	s-ttgaba	— (—)	84785	109436	100.00%	Distribution not available
3019050	s-ttgaba	U/ml (u/ml)	14864	17164	0.00%
3019050	s-ttgaba	kU/l (u/ml)	12331	14994	0.07%
3019050	s-kudostransglutaminaasi,igavasta-aineet	— (—)	3083	3199	100.00%	Distribution not available
3019050	s-ttgaba	EliAU/ml (u/ml)	2503	2633	0.00%
3019050	s-kudostransglutaminaasi,igavasta-aineet	kU/l (u/ml)	1208	1261	0.00%
3019050	s-kudostransglutaminaasi,igavasta-aineet	U/ml (u/ml)	510	535	0.00%
3019050	kudostransglutaminaasi,igavasta-aineet,seerumista	— (—)	487	508	100.00%	Distribution not available
3019050	s-kudostransglutaminaasi,iga-vasta-aineet	— (—)	295	300	100.00%	Distribution not available
3019050	s-kudostransglutaminaasi,igavasta-aineet	kU/l______ (u/ml)	238	242	0.00%
3019050	pt-keliakiatutkimus,seulonta(sis.s-iga,s-ttgaba)	— (—)	178	178	100.00%	Distribution not available
3019050	kudostransglutaminaasi,igavasta-aineet,seerumista	U/ml (u/ml)	152	169	0.00%
3019050	kudostransglutaminaasi,igavasta-aineet	kU/l (u/ml)	67	68	0.00%
3019050	s-ttgaba,s-kudostransglutaminaasi,igavasta-aineet	— (—)	66	68	100.00%	Distribution not available
3019050	s-ttgaba	EliA_U/ml (u/ml)	66	69	0.00%
3019050	s-ttgaba	U/ml______ (u/ml)	62	77	0.00%
3019050	kudostransglutaminaasi,igavasta-aineet	— (—)	60	62	100.00%	Distribution not available
3019050	kudostransglutaminaasi,iga-vasta-aineet	— (—)	34	36	100.00%	Distribution not available
3019050	s-kudostransglutaminaasi,iga-vasta-aineet	kU/l (u/ml)	32	33	0.00%
3019050	pt-kelia-m,s-ttgaba	— (—)	20	21	100.00%	Distribution not available
3019050	s-kudostransglutaminaasi,igavasta-aineet	U/ml______ (u/ml)	11	20	0.00%	Distribution not available
3019050	s-keliab,s-ttgaba	— (—)	11	11	100.00%	Distribution not available
3019050	s-kudostransglutaminaasiigava:t	— (—)	10	10	100.00%	Distribution not available
3019050	keliakia,kudostransglutaminaasiigavasta-aineet	— (—)	9	9	100.00%	Distribution not available
3019050	s-ttgaba	EliAU/m (u/ml)	9	9	0.00%	Distribution not available
3019050	keliakiatutkimus,seulonta(sis.s-iga,s-ttgaba)	— (—)	6	6	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dyspnoea

15247

81409

1.48

323.31

1.4

1.3

1.47

1.67

u/ml

1.09

4077

22425

Disorders of eyelid, lacrimal system and orbit

14811

80148

1.49

319.28

1.4

1.3

1.41

1.66

u/ml

1.80

3959

22054

Other diseases of upper respiratory tract

18826

74323

1.43

318.55

1.4

1.3

1.55

1.72

u/ml

0.90

4811

20794

Other diseases of anus and rectum

4681

27092

2.00

318.47

1.4

1.3

1.21

1.85

u/ml

4.99

1185

7421

Benzodiazepine use

17570

89682

1.44

318.38

1.4

1.3

1.36

1.67

u/ml

2.71

4506

25364

Symptoms and signs involving cognition, perception, emotional state and behaviour

16681

83666

1.45

317.45

1.4

1.3

1.55

1.66

u/ml

0.48

4280

23547

Diabetic maculopathy, excluding more controls

2037

9032

3.10

316.30

2.0

1.3

1.82

1.99

u/ml

0.24

705

2384

Symptoms and signs involving the nervous and musculoskeletal systems

9848

68625

1.62

315.67

1.4

1.3

1.36

1.67

u/ml

2.14

3104

18234

Rotator cuff syndrome

9463

44403

1.63

310.49

1.4

1.3

1.45

1.83

u/ml

2.43

2797

12235

Polyneuropathies and other disorders of the peripheral nervous system

3390

18167

2.29

309.61

1.4

1.3

1.44

1.84

u/ml

1.19

764

4742

Certain infectious and parasitic diseases, including avohilmo

12346

43849

1.54

308.35

1.4

1.3

1.68

1.77

u/ml

0.26

3410

12311

Diseases of the skin and subcutaneous tissue

17705

63157

1.55

307.65

1.4

1.3

1.65

1.67

u/ml

0.05

4874

17683

Other diseases of liver

3689

18004

2.82

307.65

1.5

1.3

1.40

1.73

u/ml

0.82

868

5026

Hypothyroidism and >3 levothyroxin purchases

5951

15644

2.76

307.65

1.5

1.2

1.59

1.96

u/ml

1.34

1941

4851

General symptoms and signs

20504

69815

1.66

307.65

1.4

1.3

1.55

1.72

u/ml

1.12

5740

19635

Benign neoplasm of colon, rectum, anus and anal canal

10475

53326

1.94

307.65

1.3

1.77

1.70

u/ml

0.17

2450

14210

Benign neoplasm: Colon

8713

48909

1.96

307.65

1.3

1.71

1.74

u/ml

0.07

2042

12834

ILD medications

20843

82152

1.51

307.65

1.4

1.3

1.31

1.76

u/ml

7.33

5676

22973

Other intervertebral disc disorders

14054

58230

1.60

307.65

1.3

1.55

1.76

u/ml

1.08

3782

16227

Insulin medication

11260

54435

2.05

307.65

1.8

1.3

1.90

1.78

u/ml

0.38

3434

14552

Asthma (diagnoses ohter than nonallergic)

15590

93748

1.48

307.65

1.4

1.3

1.53

1.67

u/ml

0.63

4262

25797

Type 1 diabetes, wide definition

6069

23580

4.29

307.65

2.2

1.3

2.08

1.88

u/ml

0.52

1964

6511

Insulin, fast-acting

8191

37147

3.11

307.65

2.0

1.3

1.97

1.75

u/ml

0.78

2642

9970

Type1 diabetes, definitions combined, early onset

2033

8091

5.76

307.65

2.7

1.4

2.38

1.94

u/ml

0.62

597

2182

General examination and investigation of persons without complaint and reported diagnosis

11042

35762

1.81

307.65

1.4

1.3

1.36

1.75

u/ml

3.10

3815

10465

Abnormalities of breathing

17101

65863

1.68

307.65

1.4

1.3

1.52

1.74

u/ml

1.33

4760

18715

Autoimmune diseases related-to ILD

16200

90975

1.70

307.65

1.4

1.3

1.44

1.68

u/ml

1.73

4395

25369

Diseases of the musculoskeletal system and connective tissue

10392

34626

1.69

307.65

1.4

1.3

1.53

1.96

u/ml

2.52

2963

9653

ILD medications: prednisolone, methylprednisolone, prednisone

19607

79939

1.50

307.65

1.4

1.3

1.35

1.75

u/ml

5.18

5313

22427

Inflammatory bowel disease treatment related agents

21360

84478

1.56

307.65

1.4

1.3

1.33

1.75

u/ml

6.21

5889

23517

Sleep disorders (combined)

20888

74300

1.66

307.65

1.4

1.3

1.31

1.81

u/ml

7.71

5837

20179

Insulin, combination of fast acting with intermediate-acting or long-acting

11265

59201

2.06

307.65

1.8

1.3

1.90

1.75

u/ml

0.53

3435

15653

Asthma, including avohilmo

21541

88101

1.48

307.65

1.4

1.3

1.50

1.72

u/ml

1.75

6093

24204

Other/unspecified dorsalgia

6488

40516

1.83

307.65

1.4

1.3

1.64

1.75

u/ml

0.24

1679

11194

ILD medications: immunosuppressive drugs

11637

73360

1.62

307.65

1.4

1.3

1.24

1.74

u/ml

6.25

3177

20578

Functional dyspepsia

5478

28486

2.50

307.65

1.4

1.3

1.10

1.71

u/ml

6.01

1380

8122

Hypothyroidism, levothyroxine purchases

5951

15644

2.76

307.65

1.5

1.2

1.59

1.96

u/ml

1.34

1941

4851

Insulin, fast-acting (human)

3611

14153

4.20

307.65

2.1

1.3

2.24

1.60

u/ml

1.79

1204

4048

Other headache syndromes

8457

51234

1.99

307.65

1.4

1.3

1.32

1.69

u/ml

2.10

2329

14318

Hypothyreosis and Thyroxine purchase for inclusion criteria

17105

77889

1.63

307.65

1.4

1.3

1.49

1.60

u/ml

0.68

5120

21189

Diseases of liver

6603

34604

2.44

307.65

1.4

1.3

1.72

1.73

u/ml

0.01

1493

9535

Other noninfective gastroenteritis and colitis

5151

26913

2.52

307.65

1.5

1.4

1.32

1.82

u/ml

2.74

1358

7232

Asthma, unspecified (mode)

9622

46890

1.67

307.65

1.4

1.3

1.40

1.73

u/ml

1.69

2600

13400

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

16724

69488

1.59

307.65

1.6

1.3

1.76

1.72

u/ml

0.13

4907

19046

Atopic dermatitis

11953

66586

1.64

307.65

1.4

1.3

1.48

1.65

u/ml

0.80

3247

18995

Hypothyroidism (congenital or acquired)

6003

15714

2.77

307.65

1.5

1.2

1.60

1.96

u/ml

1.31

1959

4872

Insulin, intermediate and long-acting

10584

54547

2.34

307.65

1.8

1.3

1.94

1.78

u/ml

0.57

3213

14360

Opioids

18125

67117

1.54

307.65

1.4

1.3

1.50

1.68

u/ml

1.02

5018

19333

Insulin, fast-acting or short human

8209

37824

3.01

307.65

2.0

1.3

1.97

1.73

u/ml

0.89

2646

10130

Neurological diseases, wide definition

6203

16940

2.19

307.65

1.4

1.3

1.74

2.09

u/ml

0.91

1779

4792

Other antidepressants

19629

62876

1.83

307.65

1.4

1.3

1.45

1.82

u/ml

3.39

5313

17804

Mycoses, including avohilmo

16718

94099

1.49

307.65

1.4

1.3

1.54

1.67

u/ml

0.64

4529

26183

Diseases of the eye and adnexa

14726

53561

1.51

307.65

1.4

1.3

1.86

1.64

u/ml

1.03

4255

15302

Sleep apnoea, including avohilmo

17323

75627

1.53

307.65

1.4

1.3

1.36

1.74

u/ml

4.29

5032

20747

Depression medications

6543

16596

2.46

307.65

1.4

1.2

1.67

1.91

u/ml

0.61

1866

5125

Other functional intestinal disorders

9533

43890

2.49

307.65

1.5

1.3

1.42

1.78

u/ml

2.16

2554

11908

Chronic rhinitis, nasopharyngitis and pharyngitis

6074

37941

1.91

307.65

1.4

1.3

1.58

1.67

u/ml

0.19

1480

10881

Conjunctivitis (acute, non atopic), including avohilmo

17851

80718

1.46

307.65

1.4

1.3

1.56

1.68

u/ml

0.62

4994

22248

Dorsopathies

19031

68688

1.55

307.65

1.4

1.3

1.36

1.80

u/ml

5.21

5439

18958

Spondylopathies

12621

50532

1.64

307.65

1.3

1.24

1.84

u/ml

7.56

3692

13887

Other diseases of urinary system

17239

70645

1.51

307.65

1.4

1.3

1.59

1.68

u/ml

0.42

4775

19530

Osteoporosis

4778

22999

2.42

307.65

1.4

1.3

1.18

1.70

u/ml

3.62

1442

5531

Type 1 diabetes, strict (exclude DM2)

2925

10922

5.55

307.65

2.5

1.4

2.14

1.94

u/ml

0.31

893

2968

GASTRO-related operations

15596

51362

1.72

307.65

1.4

1.3

1.48

1.72

u/ml

1.57

4214

15157

Disorders of the thyroid gland

17512

78475

1.63

307.65

1.4

1.3

1.51

1.64

u/ml

0.79

5232

21364

Intestinal infectious diseases

17560

93202

1.56

307.65

1.5

1.3

1.53

1.69

u/ml

0.97

4772

25788

Diseases of the digestive system

8293

46160

2.16

307.65

1.8

1.3

7.26

1.18

u/ml

76.75

2768

11860

Diabetes mellitus

18538

78293

1.51

307.65

1.6

1.3

1.73

1.65

u/ml

0.34

5461

21658

Anxiety disorders, excluding more controls

16600

67216

1.85

307.65

1.4

1.3

1.42

1.71

u/ml

2.15

4308

19419

Sleep disorders

17883

83207

1.70

307.65

1.4

1.3

1.25

1.72

u/ml

7.31

5227

22928

Asthma, excluding more controls

14042

48456

1.68

307.65

1.4

1.3

1.51

1.76

u/ml

1.29

3994

14005

Anxiety disorders

18301

82473

1.77

307.65

1.4

1.3

1.42

1.70

u/ml

2.26

4754

23497

Asthma (only as main-diagnosis), excluding more controls

13082

48456

1.69

307.65

1.4

1.3

1.52

1.76

u/ml

1.29

3761

14005

Osteopathies and chondropathies

9970

59798

1.76

307.65

1.4

1.3

1.47

1.65

u/ml

0.77

2816

15868

Diseases of oesophagus, stomach and duodenum

21474

78226

1.90

307.65

1.4

1.3

1.70

1.62

u/ml

0.36

5483

22419

Autoimmune diseases excluding thyroid diseases

21700

69844

1.99

307.65

1.6

1.2

3.13

1.16

u/ml

44.22

6402

18553

Autoimmune diseases

23228

70395

1.97

307.65

1.6

1.2

2.61

1.17

u/ml

32.55

6939

18686

Anxiety (asthma-related co-morbidities)

13240

62331

1.94

307.65

1.4

1.3

1.39

1.66

u/ml

1.80

3384

18518

Other diseases of intestines

22853

75149

2.02

307.65

1.4

1.3

1.41

1.77

u/ml

4.37

6301

21387

Anaemias

5945

15082

3.66

307.65

1.5

1.3

1.68

1.96

u/ml

0.80

1677

4594

Intestinal infectious diseases, including avohilmo, including avohilmo

22757

82540

1.76

307.65

1.4

1.3

1.50

1.74

u/ml

2.00

6317

22542

Psychiatric diseases

16845

60293

1.54

307.65

1.4

1.3

1.65

1.81

u/ml

0.75

4573

16924

Soft tissue disorders

19179

68670

1.59

307.65

1.4

1.3

1.47

1.78

u/ml

2.82

5382

19190

Episodal and paroxysmal disorders

20501

73411

1.57

307.65

1.4

1.3

1.36

1.78

u/ml

5.06

5766

20178

Asthma

14401

50240

1.66

307.65

1.4

1.3

1.51

1.76

u/ml

1.43

4088

14469

Used for control exclusion in common control thyroid runs

21747

65498

1.97

307.65

1.5

1.2

2.53

1.17

u/ml

28.29

6453

17437

Persons encountering health services for examination and investigation

10835

35776

1.68

307.65

1.4

1.3

1.83

1.75

u/ml

0.22

2948

10466

Cough

7252

43147

1.81

307.65

1.4

1.3

1.56

1.83

u/ml

0.83

1843

11735

Other soft tissue disorders, not elsewhere classified

18825

68011

1.83

307.65

1.4

1.3

1.37

1.78

u/ml

4.55

5053

19013

Dermatitis

11540

73918

1.76

307.65

1.4

1.3

1.56

1.65

u/ml

0.38

3353

20203

Type 1 diabetes, definitions combined

2939

10990

5.50

307.65

2.5

1.4

2.14

1.94

u/ml

0.30

897

2992

Type 1 diabetes, strict definition, subgroup 1

2468

8808

6.84

307.65

2.6

1.4

2.22

1.95

u/ml

0.38

758

2452

Other and unspecified iron deficiency

6860

35915

2.45

307.65

1.5

1.3

1.84

1.65

u/ml

0.56

1824

9592

Disease of hard tissues of teeth, NOS

8656

28367

1.81

307.65

1.3

1.82

1.77

u/ml

0.09

2325

7994

Insomnia

17642

83884

1.67

307.65

1.4

1.3

1.25

1.69

u/ml

6.64

5166

23203

Other and unspecified dermatitis

9713

62862

1.80

307.65

1.4

1.3

1.57

1.65

u/ml

0.30

2847

17206

Depression

19457

84134

1.80

307.65

1.4

1.3

1.41

1.69

u/ml

2.26

4996

23971

Recurrent or chronic depression

8544

30285

2.46

307.65

1.4

1.3

1.31

1.97

u/ml

5.25

2310

8803

Gastrointestinal diseases

12246

34597

2.09

307.65

1.4

1.3

2.02

1.31

u/ml

5.59

3445

9967

Diabetes, insulin treatment (Kela reimbursement)

17443

74192

1.55

307.65

1.6

1.3

1.73

1.71

u/ml

0.05

5093

20248

Mood disorders

20407

85786

1.75

307.65

1.4

1.3

1.45

1.68

u/ml

1.69

5225

24341

Constipation

17602

71501

1.98

307.65

1.4

1.3

1.30

1.76

u/ml

6.05

4557

19648

Nonalcoholic fatty liver disease

2245

9862

3.54

307.65

1.5

1.3

1.13

1.96

u/ml

4.71

522

2808

First line medication for Crohn's disease

20036

80537

1.46

307.65

1.4

1.3

1.30

1.77

u/ml

7.92

5480

22613

Asthma (mode)

14333

50557

1.68

307.65

1.4

1.3

1.52

1.76

u/ml

1.35

4109

14557

Other diseases of hard tissues of teeth

8621

28844

1.72

307.65

1.3

1.85

1.78

u/ml

0.14

2187

8093

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

18376

83668

1.68

307.65

1.4

1.3

1.80

1.61

u/ml

1.07

4736

23399

Other and unspecified anaemias

6709

37360

1.96

307.65

1.4

1.3

1.66

1.75

u/ml

0.20

1512

9582

Iron deficiency anaemia

8086

45100

2.15

307.65

1.4

1.3

1.79

1.66

u/ml

0.39

2139

11999

Autoimmune diseases excluding thyroid diseases, strict definition

21053

67999

1.99

307.65

1.6

1.2

3.16

1.17

u/ml

42.95

6208

18082

Migraine

11374

55915

1.92

307.65

1.4

1.3

1.41

1.69

u/ml

1.57

3249

15763

Depression or dysthymia

12325

38084

2.08

307.65

1.4

1.3

1.53

1.99

u/ml

2.79

3302

10624

Pain in joint

12254

39080

2.36

307.65

1.4

1.3

1.54

1.93

u/ml

2.29

3119

10907

Medical observation and evaluation for suspected diseases and conditions

12216

35776

2.03

307.65

1.4

1.3

1.65

1.75

u/ml

0.34

3047

10466

Any reimbursement code in KELA

11819

41270

1.61

307.65

1.5

1.3

1.60

1.79

u/ml

0.82

3390

11955

Dysphagia

4066

21940

2.23

307.65

1.4

1.3

1.40

1.79

u/ml

1.10

1015

5817

Dentofacial anomalies [including malocclusion]

13878

77291

1.60

307.65

1.4

1.3

1.23

1.64

u/ml

5.06

4061

21824

Dermatitis and eczema

21950

87212

1.70

307.65

1.4

1.3

1.57

1.70

u/ml

0.80

6145

24024

Irritable bowel syndrome

7616

30512

4.02

307.65

1.5

1.3

0.95

1.69

u/ml

11.23

2049

8784

Noninfective enteritis and colitis

9465

55727

2.09

307.65

1.5

1.3

1.23

1.76

u/ml

5.56

2518

15426

Lower back pain or/and sciatica

20718

88166

1.65

307.65

1.4

1.3

1.42

1.69

u/ml

2.40

5930

24365

Neurological diseases

16264

56150

1.63

307.65

1.4

1.3

1.55

1.80

u/ml

1.44

4592

15612

Asthma (only as main-diagnosis)

13340

50240

1.67

307.65

1.4

1.3

1.51

1.76

u/ml

1.45

3832

14469

Diaphragmatic hernia

5858

34684

2.01

307.65

1.4

1.3

1.48

1.69

u/ml

0.73

1345

9119

Any gastric operation

15596

51362

1.72

307.65

1.4

1.3

1.48

1.72

u/ml

1.57

4214

15157

Hypothyroidism, strict autoimmune, 3 medication purchases required

15229

73419

1.56

307.65

1.4

1.3

1.47

1.55

u/ml

0.36

4598

20036

Dorsalgia

19239

67907

1.70

307.65

1.4

1.3

1.41

1.78

u/ml

3.71

5505

18817

Oral corticosteroids

18943

80427

1.52

307.65

1.4

1.3

1.36

1.72

u/ml

4.16

5296

22495

Behavioural syndromes associated with physiological disturbances and physical factors

18630

84760

1.71

307.65

1.4

1.3

1.31

1.74

u/ml

6.19

5378

23245

Other joint disorders

16451

62815

1.50

307.65

1.4

1.3

1.34

1.78

u/ml

4.88

4666

17632

Codeine

17629

65721

1.63

307.65

1.4

1.3

1.41

1.68

u/ml

2.13

4803

18954

Other dorsopathies, not elsewhere classified

19270

68162

1.65

307.65

1.4

1.3

1.48

1.78

u/ml

2.35

5477

18872

Acute upper respiratory infections

18420

82959

1.45

307.65

1.4

1.3

1.56

1.67

u/ml

0.58

5044

22713

Endocrine, nutritional and metabolic diseases

16132

51833

1.81

307.65

1.5

1.3

1.64

1.79

u/ml

0.68

4654

14442

Mood disorders, excluding more controls

18360

69317

1.80

307.65

1.4

1.3

1.49

1.71

u/ml

1.27

4686

19925

Tramadol

14043

56597

1.68

307.65

1.4

1.3

1.49

1.72

u/ml

1.17

3575

16285

Hypothyroidism, other/unspecified

16551

74667

1.65

307.65

1.4

1.3

1.50

1.61

u/ml

0.63

4980

20333

Sciatica+with lumbago

9314

52109

1.83

307.65

1.4

1.3

1.49

1.77

u/ml

1.26

2753

14550

Shoulder lesions

12442

50319

1.65

307.65

1.4

1.3

1.52

1.78

u/ml

1.45

3572

14108

Parasetamol

13702

45909

1.69

307.65

1.4

1.3

1.50

1.92

u/ml

3.24

4016

12584

Spondylosis

8809

42081

1.88

307.65

1.4

1.3

1.22

1.85

u/ml

6.73

2612

11308

Nerve, nerve root and plexus disorders

18421

81432

1.49

307.65

1.4

1.3

1.59

1.63

u/ml

0.17

5174

22700

Other anaemias

6765

37662

1.96

307.65

1.4

1.3

1.67

1.74

u/ml

0.17

1527

9665

Cystitis

15429

64230

1.60

307.65

1.4

1.3

1.54

1.64

u/ml

0.44

4444

17653

Codeine or tramadol medication

20648

80481

1.55

307.65

1.4

1.3

1.47

1.67

u/ml

1.33

5603

22811

Diabetes, varying definitions

18301

78311

1.49

307.65

1.6

1.3

1.72

1.65

u/ml

0.26

5373

21685

Persons encountering health services for other counselling and medical advice, not elsewhere classified

20355

76649

1.57

307.65

1.4

1.3

1.61

1.73

u/ml

0.71

5943

20823

Persons encountering health services in other circumstances, wide

20869

76744

1.54

307.65

1.4

1.3

1.55

1.73

u/ml

1.22

5993

20839

Selective serotonin reuptake inhibitors

18244

63378

1.68

307.65

1.4

1.3

1.42

1.85

u/ml

4.47

4823

17880

Malaise and fatigue

9219

46001

1.81

307.65

1.4

1.3

1.29

1.73

u/ml

3.53

2335

12436

Symptoms and signs involving the digestive system and abdomen

18999

59650

1.82

307.65

1.4

1.3

1.65

1.84

u/ml

0.98

5182

16538

Pain in limb

16143

66339

1.78

307.65

1.4

1.3

1.50

1.76

u/ml

1.72

4214

18514

Diabetes medication

18676

80360

1.49

307.65

1.6

1.3

1.70

1.65

u/ml

0.18

5481

22204

Aplastic and other anaemias

7174

40262

1.88

307.65

1.4

1.3

1.63

1.73

u/ml

0.27

1621

10391

Follow-up examination after treatment for conditions other than malignant neoplasms

7765

31319

1.90

307.65

1.4

1.3

2.16

1.67

u/ml

1.50

1617

9143

Abdominal and pelvic pain

19024

59644

1.83

307.65

1.4

1.3

1.66

1.84

u/ml

0.89

5277

16537

Nausea and vomiting

4804

27230

2.05

307.65

1.5

1.3

1.67

1.84

u/ml

0.34

1284

7149

Type 1 diabetes

6549

26644

3.83

307.65

2.2

1.3

2.04

1.82

u/ml

0.64

2093

7360

Abnormalities of heart beat

6349

38044

1.88

307.65

1.4

1.3

1.31

1.73

u/ml

2.65

1699

10507

Pain, not elsewhere classified

5284

31725

1.99

307.65

1.4

1.3

1.31

1.75

u/ml

1.90

1477

8847

Myalgia

4702

27134

2.15

307.65

1.4

1.3

1.38

1.81

u/ml

1.38

1071

7722

Examination and observation for other reasons

12525

35650

2.45

307.65

1.4

1.3

2.12

1.75

u/ml

1.39

2911

10427

Low back pain

15525

65974

1.85

307.65

1.4

1.3

1.35

1.77

u/ml

4.28

4383

18356

Other disorders of urethra and urinary system

12429

61099

1.58

307.65

1.4

1.3

1.52

1.61

u/ml

0.38

3283

16805

Symptoms and signs involving the circulatory and respiratory systems

19383

66045

1.65

307.65

1.4

1.3

1.51

1.74

u/ml

1.60

5395

18780

Metabolic disorders

15864

70345

1.48

307.65

1.4

1.3

1.66

1.70

u/ml

0.16

4172

19909

Headache

14322

66524

1.99

307.65

1.4

1.3

1.36

1.68

u/ml

2.29

3931

18709

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6854

19412

2.03

307.65

1.4

1.3

1.48

2.06

u/ml

2.72

1916

5720

Pain in throat and chest

16326

63516

1.73

307.65

1.4

1.3

1.56

1.74

u/ml

0.90

4346

18059

Hypothyroidism, strict autoimmune

13988

57480

1.85

307.65

1.4

1.2

1.53

1.12

u/ml

4.12

4269

15316

Other special examinations and investigations of persons without complaint or reported diagnosis

11696

35776

1.89

307.65

1.4

1.3

1.68

1.75

u/ml

0.23

3333

10466

Symptoms and signs concerning food and fluid intake

2217

9919

3.13

307.65

1.5

1.4

1.56

1.97

u/ml

0.82

568

2549

Chronic gastritis

4177

22332

2.25

307.65

1.4

1.3

2.27

1.77

u/ml

0.78

765

5859

Coeliac disease

3321

12800

4.95

307.65

2.4

1.3

12.58

1.20

u/ml

85.33

1500

3364

Diverticular disease of intestine

12216

42092

2.12

307.65

1.3

1.46

1.82

u/ml

2.08

3032

11694

Collagenous colitis

2105

8762

3.91

307.65

1.5

1.3

1.27

1.60

u/ml

0.70

566

2384

Mood [affective] disorders

20390

85768

1.76

307.65

1.4

1.3

1.46

1.68

u/ml

1.63

5220

24335

All anxiety disorders

13622

66965

1.89

307.65

1.5

1.3

1.37

1.67

u/ml

2.26

3479

19763

Other anxiety disorders

10352

55322

1.93

307.65

1.5

1.3

1.32

1.65

u/ml

2.27

2569

16512

Any mental disorder

18946

70176

1.48

307.65

1.4

1.3

1.70

1.72

u/ml

0.07

4897

20058

Type 1 diabetes, strict definition

2558

9266

6.50

307.65

2.6

1.4

2.27

1.94

u/ml

0.50

782

2564

Neurotic, stress-related and somatoform disorders

18188

82139

1.78

307.65

1.4

1.3

1.43

1.70

u/ml

2.19

4719

23425

Haemorrhoids and perianal venous thrombosis

5363

30947

2.00

307.65

1.3

1.64

1.82

u/ml

0.41

1467

8550

Asthma, unspecified (mode), excluding more controls

9447

45191

1.69

307.65

1.4

1.3

1.39

1.72

u/ml

1.65

2561

12962

Type 1 diabetes, wide definition, subgroup 1

5971

22527

4.66

307.65

2.2

1.3

2.06

1.86

u/ml

0.51

1936

6259

Sub-endpoint used in defining T1D endpoints

6633

29282

3.10

307.65

2.1

1.3

2.04

1.80

u/ml

0.76

2128

8010

Disorders of thyroid, IBD co-morbidities

3545

11460

2.64

307.65

1.5

1.2

1.62

1.99

u/ml

0.89

1002

3354

Diarrhoea and gastroenteritis of presumed infectious origin

12903

81479

1.58

307.65

1.5

1.3

1.52

1.69

u/ml

0.83

3589

22739

Other specific joint derangements/joint disorders

15020

61674

1.76

307.65

1.4

1.3

1.52

1.77

u/ml

1.39

4044

17351

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

20425

84200

1.80

307.65

1.4

1.3

1.47

1.73

u/ml

2.19

5915

22995

Other and unspecified polyneuropathies, also in other diseases

3042

15390

2.49

307.65

1.5

1.3

1.38

1.90

u/ml

1.61

684

3991

Gastro-oesophageal reflux disease

13594

65352

2.13

307.65

1.4

1.3

1.55

1.65

u/ml

0.41

3325

18470

Sleep apnoea

15928

72764

1.52

307.65

1.4

1.3

1.33

1.76

u/ml

5.42

4564

19962

Pain (limb, back, neck, head abdominally)

12965

39833

1.85

307.65

1.4

1.3

1.80

1.97

u/ml

0.64

3571

11063

Nutritional anaemias

9149

50768

2.06

307.65

1.4

1.3

1.87

1.64

u/ml

0.84

2370

13503

Infections, IBD-co-morbidities

2558

8373

2.59

307.34

1.4

1.2

1.79

2.29

u/ml

0.79

638

2363

Other disorders of lacrimal gland

6504

42048

1.82

307.26

1.4

1.3

1.39

1.69

u/ml

1.24

1791

11525

Migraine, single triptan purchase ok & required. ICD-code if available is included

14438

72723

1.50

305.58

1.4

1.3

1.30

1.68

u/ml

3.65

4232

20455

Triptan medication for migraine, single purchase ok

14438

72723

1.50

305.58

1.4

1.3

1.30

1.68

u/ml

3.65

4232

20455

Personality disorders, excluding more controls

5058

30838

1.99

304.59

1.5

1.3

1.66

1.62

u/ml

0.07

1264

9561

Temporomandibular joint disorders, including avohilmo

9245

62724

1.67

304.52

1.4

1.19

1.58

u/ml

3.19

2626

17992

Disorders of gallbladder, biliary tract and pancreas

16185

75694

1.45

299.80

1.4

1.3

1.41

1.66

u/ml

1.98

4504

20951

Pain and other conditions associated with female genital organs and menstrual cycle

4670

23567

2.10

298.93

1.5

1.4

1.34

1.66

u/ml

1.09

1248

6657

Other retinal disorders

9721

51226

1.60

297.62

1.6

1.3

2.05

1.67

u/ml

1.57

2702

13335

Lumbar disc prolapse

10493

54785

1.57

295.40

1.3

1.65

1.78

u/ml

0.39

2937

15257

Persons encountering health services in other circumstances

7494

49726

1.71

293.77

1.5

1.3

1.55

1.71

u/ml

0.51

2145

13507

Dizziness and giddiness

12495

70837

1.51

293.39

1.4

1.3

1.49

1.68

u/ml

0.84

3231

19701

Diseases of oral cavity, salivary glands and jaws

8474

28934

1.65

291.99

1.3

1.79

1.78

u/ml

0.03

2203

8109

Exposure to unspecified factor

17984

94063

1.41

291.37

1.4

1.3

1.83

1.64

u/ml

0.87

4159

26769

Hypothyroidism, drug reimbursement

2684

9207

2.54

291.32

1.5

1.2

1.92

1.82

u/ml

0.11

763

2899

Acute upper respiratory infections of multiple and unspecified sites

13813

74758

1.48

290.43

1.4

1.3

1.50

1.68

u/ml

0.95

3847

20823

Other systemic involvement of connective tissue (FG)

4508

26391

2.01

290.33

1.4

1.3

1.50

1.76

u/ml

0.71

1251

7033

Other nutritional deficiencies

12184

81691

1.52

289.72

1.4

1.3

1.48

1.60

u/ml

0.53

3476

22924

Disorders of lacrimal system

7655

51006

1.70

287.18

1.4

1.3

1.41

1.64

u/ml

0.94

2107

13919

Symptoms and signs involving the skin and subcutaneous tissue

12461

86692

1.50

286.14

1.4

1.3

1.30

1.65

u/ml

3.25

3212

24068

Disorders of conjunctiva

15302

89907

1.45

284.32

1.4

1.3

1.61

1.62

u/ml

0.05

4105

25061

Other gastritis (incl. Duodenitis)

3410

18776

2.18

282.01

1.4

1.3

1.95

1.79

u/ml

0.23

881

5093

Budesonide

2835

15039

2.47

280.64

1.5

1.3

1.47

1.76

u/ml

0.60

700

4262

Other arthrosis

8042

36433

1.64

273.01

1.3

1.47

1.84

u/ml

1.64

2044

10067

Fibromyalgia

2066

10008

2.99

272.19

1.5

1.3

1.14

1.55

u/ml

0.97

604

2848

Antihypertensive medication - note that there are other indications

12312

47077

1.52

272.07

1.4

1.61

1.76

u/ml

0.57

3681

13417

Noninfectious colitis NAS

2648

13895

2.52

270.85

1.5

1.3

1.33

1.81

u/ml

1.49

728

3814

Coxibs

4436

13409

1.97

269.00

1.4

1.3

1.54

2.07

u/ml

1.60

1241

3512

Caries of enamel

16917

85405

1.41

268.41

1.4

1.3

1.56

1.69

u/ml

0.62

4179

24439

Asthma, hospital admissions , main diagnosis only

14332

94492

1.44

267.82

1.4

1.3

1.54

1.67

u/ml

0.63

4049

25999

Inflammatory bowel disease

5616

36252

1.83

267.43

1.4

1.3

1.17

1.67

u/ml

3.52

1505

10372

Asthma-related infections

10274

72415

1.54

264.70

1.4

1.3

1.56

1.67

u/ml

0.36

2764

19714

Asthma, hospital admission 2, infections

10274

72415

1.54

264.70

1.4

1.3

1.56

1.67

u/ml

0.36

2764

19714

Dental operations

8872

31194

1.60

264.04

1.3

1.84

1.75

u/ml

0.22

2350

8482

Spinal stenosis

6898

33519

1.68

263.75

1.3

1.25

1.88

u/ml

4.73

1880

8597

19580

77600

1.37

262.13

1.4

1.3

1.57

1.69

u/ml

0.64

5334

21345

Arthropathies

16323

63013

1.42

260.72

1.4

1.3

1.35

1.78

u/ml

5.10

4653

17661

Certain infectious and parasitic diseases

17145

66024

1.40

260.35

1.4

1.3

1.72

1.65

u/ml

0.24

4541

18867

Special screening examination for infectious and parasitic diseases

4838

21717

1.89

259.05

1.4

1.3

1.36

1.72

u/ml

1.31

913

6853

Disorders of synovium and tendon

9025

54054

1.57

258.90

1.4

1.3

1.68

1.70

u/ml

0.06

2549

15222

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

15879

95300

1.41

258.75

1.4

1.3

1.47

1.69

u/ml

1.55

4446

26239

Disturbances of skin sensation

5223

33580

1.86

258.16

1.4

1.3

0.96

1.69

u/ml

12.03

1333

9784

8138

56564

1.62

256.60

1.4

1.55

1.72

u/ml

0.54

2211

15582

Migraine with aura

5241

33882

1.87

256.35

1.4

1.10

1.66

u/ml

4.41

1446

9777

Other pulmonary diagnosis

13588

50695

1.46

255.98

1.4

1.3

1.46

1.76

u/ml

1.85

3694

14623

Abnormal findings on examination of blood, without diagnosis

6783

41119

1.67

254.59

1.5

1.3

1.96

1.84

u/ml

0.29

1833

10919

Systemic connective tissue disorders

5780

38000

1.77

250.74

1.4

1.3

1.40

1.67

u/ml

1.05

1554

10169

Excluding asthma or asthma-COPD overlap

13542

50695

1.45

249.40

1.4

1.3

1.50

1.76

u/ml

1.46

3697

14623

Conjunctivitis

14020

86325

1.44

248.28

1.4

1.57

1.61

u/ml

0.17

3755

24159

Weight loss

1945

9458

2.85

248.08

1.5

1.3

1.53

1.65

u/ml

0.16

496

2403

Nonorganic sleeping disorders, excluding more controls

3976

24080

2.01

247.58

1.5

1.3

1.61

1.66

u/ml

0.08

1008

7226

Chronic lower respiratory diseases

20936

87690

1.35

247.10

1.4

1.3

1.56

1.70

u/ml

0.87

5864

24258

Abnormal weight loss

1789

8455

2.98

245.57

1.5

1.3

1.61

1.71

u/ml

0.13

454

2146

Other symptoms and signs involving the digestive system and abdomen

3006

16771

2.21

245.29

1.4

1.3

1.16

1.72

u/ml

2.34

856

4555

COPD differential diagnosis

13480

50579

1.45

244.60

1.4

1.3

1.49

1.76

u/ml

1.57

3681

14562

Diabetic retinopathy, strict definition

2887

14307

2.35

244.47

2.0

1.4

2.04

1.58

u/ml

1.00

912

4103

Disorders of other endocrine glands

7800

53912

1.62

243.79

1.4

1.37

1.70

u/ml

1.79

2185

14631

ILD differential diagnosis

13468

50557

1.45

243.53

1.4

1.3

1.49

1.76

u/ml

1.57

3676

14557

Disorders of lipoprotein metabolism and other lipidaemias

12482

56433

1.46

243.07

1.4

1.3

1.79

1.72

u/ml

0.20

3080

15809

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

939

3388

5.42

242.50

2.0

1.3

2.62

1.70

u/ml

0.75

306

1072

Chronic sinusitis

7183

49520

1.64

242.13

1.4

1.3

1.41

1.66

u/ml

0.94

1822

14299

Obesity related asthma

5783

38332

1.74

241.24

1.4

1.3

1.30

1.72

u/ml

2.53

1656

10596

Disorders of choroid and retina

12120

63164

1.46

241.16

1.5

1.3

2.08

1.65

u/ml

2.08

3321

16944

Genitourinary diseases

9154

32199

1.56

240.03

1.4

1.3

1.59

2.11

u/ml

2.97

2531

8950

Oedema, not elsewhere classified

5095

31819

1.78

239.93

1.4

1.3

1.64

1.78

u/ml

0.34

1230

8511

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

8420

57642

1.57

238.87

1.4

1.3

1.59

1.72

u/ml

0.35

2250

16551

Cholelithiasis

13321

68857

1.43

237.47

1.3

1.27

1.64

u/ml

3.90

3728

18959

Non-selective monoamine reuptake inhibitors

5533

34634

1.73

237.25

1.4

1.3

1.40

1.81

u/ml

1.64

1423

9446

Osteoporosis with pathological fracture (FG)

1367

5809

3.38

236.87

1.5

1.3

1.06

1.53

u/ml

1.45

419

1388

Hernia of abdominal wall, postoperative

2841

15482

2.15

233.43

1.3

1.56

1.88

u/ml

0.56

704

4549

Bronchitis

18814

89507

1.35

232.00

1.4

1.3

1.46

1.68

u/ml

1.64

5154

24751

Gingivitis and periodontal diseases

16184

64765

1.39

231.60

1.3

1.48

1.77

u/ml

2.21

4363

18022

Other systemic involvement of connective tissue

4582

29155

1.85

231.14

1.4

1.3

1.49

1.66

u/ml

0.41

1271

7831

Fibrosis and cirrhosis of liver

1406

6124

3.28

231.11

1.5

1.3

1.88

1.51

u/ml

0.36

320

1650

Hyperkinetic disorders, excluding more controls

3106

16938

2.24

230.62

1.6

1.4

1.86

1.64

u/ml

0.32

787

5167

Dental caries

3806

21488

1.92

230.23

1.4

1.3

1.86

1.83

u/ml

0.04

881

6212

Cholecystectomy

11175

70781

1.47

230.23

1.3

1.27

1.63

u/ml

3.03

3140

19334

Cholelithiasis, broad definition with cholecystitis

13754

69902

1.42

230.04

1.3

1.30

1.64

u/ml

3.30

3844

19274

Candidiasis, including avohilmo

5625

37770

1.75

228.14

1.4

1.3

1.62

1.60

u/ml

0.03

1488

10516

Other disorders of skin and subcutaneous tissue

11538

73079

1.45

227.38

1.4

1.3

1.54

1.65

u/ml

0.45

3099

19841

Urinary track infection

11803

44389

1.49

225.75

1.4

1.3

1.43

1.56

u/ml

0.51

3406

12464

Cardiovascular diseases

12222

48868

1.47

225.45

1.4

1.58

1.73

u/ml

0.55

3599

14214

Missing teeth due to accident, extraction or parodontitis

9221

59881

1.51

224.39

1.4

1.3

1.46

1.70

u/ml

1.25

2277

16023

Other bacterial intestinal infections, including avohilmo

3848

23519

1.93

224.17

1.4

1.3

1.53

1.75

u/ml

0.45

939

6431

Cardiac arrhythmias

10544

49916

1.49

223.98

1.4

1.3

1.45

1.69

u/ml

1.26

2991

14087

Complications of surgical and medical care, not elsewhere classified

16455

86214

1.37

223.78

1.4

1.3

1.51

1.63

u/ml

0.58

4331

24124

Polyarthropathies

10811

51460

1.47

219.19

1.4

1.3

1.42

1.77

u/ml

2.30

2936

14435

Dental caries, including avohilmo

11059

41742

1.46

218.39

1.3

1.81

1.72

u/ml

0.23

2973

11336

Migraine without aura

4361

28141

1.90

218.33

1.5

1.4

1.34

1.67

u/ml

1.26

1286

8182

Dental pulpitis, including avohilmo

16265

82201

1.37

216.59

1.4

1.3

1.39

1.68

u/ml

2.61

4825

23113

Pure hypercholesterolaemia

10997

51895

1.45

215.99

1.4

1.3

1.77

1.73

u/ml

0.10

2503

14410

Excessive, frequent and irregular menstruation

7279

27160

1.64

215.21

1.4

1.39

1.68

u/ml

1.30

2051

7451

Caries of dentine

3355

19093

1.96

214.42

1.4

1.3

1.76

1.79

u/ml

0.03

786

5528

Implicit viral Sepsis, including avohilmo

4791

31055

1.76

214.20

1.4

1.3

1.91

1.80

u/ml

0.17

1197

8216

Fever of other and unknown origin

9152

57991

1.49

211.22

1.4

1.3

1.57

1.73

u/ml

0.54

2564

15969

Diseases of the ear and mastoid process

19742

79478

1.33

210.72

1.4

1.3

1.62

1.65

u/ml

0.09

5348

22567

Cervical disc disorders

5154

34011

1.70

210.07

1.4

1.3

1.22

1.88

u/ml

4.82

1418

9112

Somatoform disorder

3008

17733

2.11

209.92

1.5

1.3

1.50

1.63

u/ml

0.20

787

5196

Generalized anxiety disorder

3581

22256

2.01

209.55

1.5

1.4

1.32

1.61

u/ml

0.86

885

6663

Complications of procedures, not elsewhere classified

13242

82495

1.40

209.47

1.4

1.3

1.46

1.64

u/ml

1.01

3530

23026

Any death

4547

48576

0.60

208.52

1.2

1.3

2.11

1.74

u/ml

0.72

1006

12484

Second line medication for Crohn's disease

9659

71996

1.48

208.17

1.4

1.3

1.20

1.69

u/ml

5.92

2617

19897

Other diseases of lip and oral mucosa

7021

49796

1.59

207.98

1.4

1.3

1.46

1.65

u/ml

0.66

1758

13703

Type 2 diabetes

15969

72722

1.36

207.87

1.4

1.3

1.63

u/ml

0.00

4678

20240

Other enthesopathies

4799

31399

1.75

207.81

1.4

1.3

1.59

1.83

u/ml

0.58

1336

8819

Other reaction to severe stress, and adjustment disorders

6824

48251

1.61

207.64

1.5

1.3

1.18

1.62

u/ml

3.34

1878

14473

Inflammatory diseases of female pelvic organs

12093

63733

1.45

207.39

1.4

1.3

1.30

1.46

u/ml

0.83

3318

17976

Diseases of pulp and periapical tissues and dental caries

9891

37028

1.48

206.93

1.3

1.81

1.72

u/ml

0.21

2602

10017

Carpal tunnel syndrome

9671

62229

1.48

206.23

1.4

1.3

1.53

1.62

u/ml

0.32

2815

17139

Vasomotor and allergic rhinitis

7026

48815

1.60

206.05

1.4

1.47

1.69

u/ml

0.76

2003

14202

Cervicalgia

3371

20337

1.95

205.71

1.4

1.3

1.04

1.91

u/ml

9.13

929

5536

Visual disturbances and blindness

8540

62487

1.51

205.57

1.4

1.3

1.88

1.65

u/ml

0.66

2063

16913

Other symptoms and signs involving the nervous and musculoskeletal systems

6935

49138

1.59

204.92

1.4

1.3

1.30

1.68

u/ml

2.53

2482

13341

Factors influencing health status and contact with health services

4327

13270

1.80

204.30

1.3

1.2

2.07

1.94

u/ml

0.17

1191

3880

Finngen Rheumatological endpoints

16363

73452

1.35

204.25

1.4

1.3

1.37

1.69

u/ml

3.11

4737

20685

Heartburn

1991

10327

2.44

203.60

1.4

1.3

1.11

1.81

u/ml

3.78

512

2871

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

14923

79129

1.37

202.82

1.4

1.3

1.60

1.68

u/ml

0.31

3893

22083

Type 2 diabetes, wide definition

11624

55512

1.42

201.99

1.4

1.3

1.63

1.71

u/ml

0.26

3332

15043

Implicit Sepsis

11699

65656

1.42

201.66

1.4

1.3

1.66

1.71

u/ml

0.13

2874

17870

Other diseases of intestine

2246

12038

2.23

200.63

1.4

1.3

2.13

2.04

u/ml

0.08

485

3291

Other arrhythmias

10592

59617

1.45

200.00

1.4

1.3

1.42

1.65

u/ml

1.16

2816

16669

Caries of dentine, including avohilmo

12112

46945

1.42

199.72

1.3

1.78

1.69

u/ml

0.26

3250

12718

Implicit Sepsis, including avohilmo

13086

72396

1.39

199.60

1.4

1.3

1.65

1.67

u/ml

0.06

3273

19894

Diseases of pulp and periapical tissues, including avohilmo

17697

73157

1.34

198.93

1.4

1.3

1.70

1.66

u/ml

0.14

4832

20100

Concussion

8642

48959

1.50

198.47

1.4

1.3

1.88

1.79

u/ml

0.21

2392

13682

Statin medication

11378

48501

1.43

197.29

1.5

1.3

1.62

1.75

u/ml

0.51

3316

14323

Visual disturbances

7985

58311

1.52

197.03

1.4

1.3

1.84

1.63

u/ml

0.54

1939

15816

Faecal incontinence

1605

7831

2.69

196.23

1.4

1.3

1.31

1.65

u/ml

0.57

381

2014

Benign neoplasms

16618

71923

1.34

195.33

1.4

1.3

1.54

1.74

u/ml

1.10

4620

20606

Use of hypnotics and sedatives

17060

77887

1.34

194.92

1.3

1.37

1.73

u/ml

3.66

4454

22098

Falls/tendency to fall

18441

74296

1.33

194.78

1.4

1.3

1.79

1.61

u/ml

0.84

4835

21548

Pain in thoracic spine

2688

15591

2.10

193.24

1.4

1.3

1.14

1.90

u/ml

3.19

816

4310

Disorders of vitreous body

7346

50327

1.54

192.23

1.4

1.3

1.74

1.65

u/ml

0.22

2002

13216

Endometriosis

6024

24175

1.66

192.14

1.4

1.3

1.20

1.61

u/ml

3.01

1694

6726

Vocal cord dysfunction

2231

10570

2.21

191.84

1.4

1.2

1.73

1.82

u/ml

0.10

584

3116

Disorders of vitreous body and globe

7509

51329

1.53

191.66

1.4

1.3

1.74

1.65

u/ml

0.21

2033

13487

Personality disorders

5058

34532

1.72

190.56

1.5

1.3

1.66

1.59

u/ml

0.13

1264

10217

Rheumatism, unspecified

2301

12877

2.24

189.72

1.4

1.3

1.37

1.72

u/ml

0.67

669

3478

Cervicobrachial syndrome

3602

22602

1.86

189.12

1.4

1.3

1.11

1.87

u/ml

6.42

1135

6328

Symptoms and signs involving speech and voice

5232

35697

1.67

188.88

1.4

1.3

1.49

1.67

u/ml

0.48

1304

9742

KRA_PSY_EATING, excluding more controls

2052

11294

2.54

188.84

1.7

1.4

1.18

1.55

u/ml

1.25

571

3492

Fall on same level

19667

85338

1.31

188.70

1.4

1.3

1.85

1.64

u/ml

1.05

4957

24491

Provisional assignment of new diseases of uncertain etiology

8853

65534

1.48

188.53

1.4

1.3

1.50

1.62

u/ml

0.44

2591

18063

Viral and other specified intestinal infections, including avohilmo

5566

37155

1.66

188.50

1.5

1.4

1.62

1.70

u/ml

0.20

1631

10428

Oxicams

3113

10193

1.94

188.48

1.3

1.25

2.09

u/ml

3.48

992

2703

Triptan medication for migraine, min. 3 purchases

10938

62998

1.44

188.16

1.4

1.26

1.56

u/ml

2.24

3266

18195

Acetic acid derivatives and related substances

4047

12919

1.80

187.99

1.4

1.3

1.66

2.01

u/ml

0.72

1107

3393

Codes for special purposes

8854

65598

1.48

187.32

1.4

1.3

1.50

1.62

u/ml

0.44

2591

18073

Acute sinusitis

9315

63691

1.46

187.24

1.4

1.3

1.66

1.63

u/ml

0.09

2667

18097

Disorders of adult personality and behaviour

5362

37198

1.68

185.98

1.5

1.4

1.72

1.59

u/ml

0.28

1325

10951

Disorders of skin appendages

8928

66738

1.48

185.98

1.4

1.57

1.62

u/ml

0.16

2571

18710

Chronic diseases of tonsils and adenoids

13496

66825

1.38

185.47

1.4

1.3

1.64

1.70

u/ml

0.18

3533

19045

Hypertensive diseases (excluding secondary)

8894

38235

1.49

185.42

1.4

1.3

1.52

1.72

u/ml

0.84

2645

11153

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1352

4141

2.69

183.45

1.4

1.2

1.23

2.70

u/ml

4.05

349

1075

Care involving use of rehabilitation procedures

10312

70725

1.42

183.35

1.4

1.3

1.60

1.70

u/ml

0.34

2499

19701

Voice disturbances

4335

28744

1.76

182.79

1.4

1.3

1.53

1.67

u/ml

0.28

1101

7869

Ulcerative colitis

4078

26646

1.78

182.54

1.4

1.3

1.29

1.79

u/ml

2.24

1071

7645

Menorrhagia

5815

22375

1.65

182.53

1.4

1.3

1.26

1.64

u/ml

1.82

1614

6174

Other external causes of accidental injury

13625

53320

1.37

181.89

1.4

1.3

1.86

1.54

u/ml

1.61

3574

15893

Excessive attrition of teeth

10628

81168

1.42

181.47

1.4

1.3

1.43

1.64

u/ml

1.11

2999

22904

Irregular menses

9632

55223

1.48

181.29

1.4

1.32

1.48

u/ml

0.82

2855

15896

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2080

11307

2.23

180.73

1.4

1.3

2.67

2.00

u/ml

0.83

434

3021

Subjective visual disturbances

4307

28620

1.76

180.57

1.4

1.3

1.67

1.75

u/ml

0.15

999

7869

IBD patients in KELA-register

3967

25904

1.80

180.11

1.4

1.3

1.20

1.80

u/ml

3.06

1045

7525

Complications of medical and surgical care

11626

81232

1.39

179.26

1.4

1.3

1.55

1.62

u/ml

0.22

2802

22666

COPD/asthma/ILD related infections

17256

69685

1.32

178.92

1.4

1.3

1.63

1.70

u/ml

0.23

4718

19457

COPD/asthma related infections

17256

69685

1.32

178.92

1.4

1.3

1.63

1.70

u/ml

0.23

4718

19457

Syncope and collapse

6725

39983

1.53

178.84

1.4

1.3

1.61

1.75

u/ml

0.42

1706

10614

Haemorrhage from respiratory passages

4650

27262

1.67

178.56

1.3

1.79

1.96

u/ml

0.32

1191

7113

Obesity and other hyperalimentation

10947

79774

1.41

178.51

1.4

1.3

1.45

1.59

u/ml

0.68

3065

22579

Injuries to the ankle and foot

12786

86165

1.37

178.27

1.4

1.3

1.79

1.63

u/ml

0.56

3341

24582

Obesity

10901

79577

1.41

177.46

1.4

1.3

1.45

1.59

u/ml

0.65

3053

22522

Other specified/unspecified arthritis

4282

28347

1.72

176.35

1.4

1.3

1.32

1.85

u/ml

2.76

1205

7813

Pruritus

2136

12021

2.26

175.34

1.5

1.3

1.18

1.65

u/ml

1.34

565

3315

Soft tissue disorders related to use, overuse and pressure

4079

26744

1.73

173.11

1.4

1.3

1.28

1.86

u/ml

4.00

1073

7234

Other disorders of fluid, electrolyte and acid-base balance

4376

27306

1.69

172.89

1.4

1.3

1.69

1.77

u/ml

0.13

1174

7142

L04AX Other immunosuppressants

9135

69462

1.44

171.90

1.4

1.3

1.20

1.68

u/ml

5.43

2472

19112

Fissure and fistula of anal and rectal regions

3523

22379

1.79

171.21

1.4

1.3

1.25

1.85

u/ml

2.69

927

6417

Noninflammatory disorders of female genital tract

7468

27316

1.54

170.86

1.4

1.37

1.69

u/ml

1.48

2082

7483

5-aminosalicylic acid

3597

23252

1.81

168.64

1.4

1.3

1.28

1.85

u/ml

2.20

912

6708

Accidents

13511

53320

1.36

168.54

1.4

1.3

1.87

1.54

u/ml

1.68

3560

15893

Reimbursement for rheumatic diseases

9002

68066

1.44

167.73

1.4

1.3

1.18

1.64

u/ml

5.25

2498

18506

Chronic apical periodontitis

18612

85630

1.29

167.39

1.4

1.3

1.68

1.62

u/ml

0.23

5077

24011

Hypertension, essential

11995

52855

1.38

167.10

1.4

1.3

1.68

1.66

u/ml

0.04

3470

15126

Intestinal malabsorption

959

4152

3.57

165.96

1.7

1.3

2.72

1.23

u/ml

2.17

293

1131

Ovarian cyst

6184

25226

1.59

164.71

1.4

1.3

1.43

1.60

u/ml

0.45

1742

7009

Specific personality disorders

4373

29887

1.72

164.50

1.5

1.3

1.78

1.59

u/ml

0.35

1100

8817

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4839

29553

1.71

163.81

1.6

1.4

1.79

1.69

u/ml

0.17

1242

8577

Inflammatory bowel disease, strict (require KELA)

3967

26462

1.75

163.79

1.4

1.20

1.77

u/ml

2.86

1045

7680

Asthma/COPD (KELA code 203)

16130

87569

1.31

163.55

1.4

1.3

1.57

1.70

u/ml

0.67

4494

24226

Urticaria and erythema

6394

46710

1.55

161.87

1.4

1.58

1.70

u/ml

0.34

1746

13086

Cirrhosis of liver, NAS

932

3954

3.36

161.64

1.4

1.3

2.52

1.44

u/ml

0.89

205

1051

Other symptoms and signs involving cognitive functions and awareness

6500

41588

1.51

161.48

1.4

1.3

1.74

1.72

u/ml

0.02

1494

10891

Other arthritis (FG)

4859

33628

1.63

160.83

1.4

1.3

1.34

1.77

u/ml

2.24

1376

9174

Other inflammation of eyelid, including avohilmo

8088

61234

1.46

160.39

1.4

1.3

1.66

1.63

u/ml

0.07

2136

17363

Polyuria

3119

19577

1.83

160.21

1.4

1.3

1.74

1.78

u/ml

0.06

700

5146

Benign neoplasm: Colon, unspecified

3371

21560

1.79

160.08

1.3

1.83

u/ml

0.00

729

5542

Diseases of the respiratory system

10766

41564

1.40

159.87

1.4

1.3

1.54

1.78

u/ml

0.98

2948

11780

Migraine without aura and triptan purchases

3486

23052

1.86

159.48

1.5

1.4

1.21

1.65

u/ml

1.88

1039

6752

Migraine with aura and triptan purchases

3367

22106

1.88

159.44

1.4

1.04

1.65

u/ml

3.76

953

6461

Symptoms and signs involving the urinary system

11334

66919

1.37

159.25

1.4

1.3

1.61

1.71

u/ml

0.39

2847

18179

Nonorganic sleeping disorders

3976

26805

1.75

159.07

1.5

1.4

1.61

1.65

u/ml

0.07

1008

7751

Exposure to other specified factors

13637

94194

1.33

159.05

1.4

1.3

1.70

1.65

u/ml

0.13

3404

26578

Other extrapyramidal and movement disorders in other diseases

3762

24857

1.75

158.84

1.4

1.3

1.45

1.75

u/ml

0.68

950

6714

Condition for Implicit Sepsis (Organ dysfunction codes)

13393

74087

1.34

158.41

1.4

1.3

1.61

1.67

u/ml

0.19

3344

20526

Atopic dermatitis, strict definition with reimbursement

5830

40513

1.58

157.97

1.5

1.4

1.85

1.69

u/ml

0.37

1603

11690

Intracranial trauma

9618

49802

1.40

156.14

1.4

1.3

1.87

1.78

u/ml

0.24

2651

13937

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

9899

74011

1.40

155.57

1.4

1.3

1.43

1.57

u/ml

0.63

2637

20880

Postmenopausal atrophic vaginitis

3885

13883

1.75

152.84

1.3

1.15

1.81

u/ml

3.09

1092

3662

Allergic conjunctivitis

10317

78087

1.39

152.80

1.4

1.41

1.59

u/ml

0.97

2762

22009

Presence of other functional implants

8037

41193

1.44

151.78

1.4

1.3

1.45

1.76

u/ml

1.57

2447

10596

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

4862

33711

1.61

151.70

1.4

1.3

1.38

1.63

u/ml

0.71

1258

10369

Persons encountering health services for specific procedures and health care

17985

87720

1.28

151.19

1.4

1.3

1.66

1.67

u/ml

0.03

4591

24871

Injuries to the abdomen, lower back, lumbar spine and pelvis

6270

45198

1.51

149.87

1.4

1.3

1.73

1.69

u/ml

0.10

1618

12226

Postmenopausal osteoporosis with pathological fracture

1119

5336

2.90

149.47

1.5

1.3

1.12

1.34

u/ml

0.43

336

1275

Dermatophytosis, including avohilmo

10534

81331

1.37

148.58

1.4

1.3

1.47

1.68

u/ml

1.13

2891

22746

Fenamates

2198

8545

2.03

148.30

1.4

1.3

1.07

1.89

u/ml

2.37

563

2292

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

9443

63558

1.39

148.24

1.4

1.3

1.64

1.67

u/ml

0.09

2353

17046

Panic disorder

2949

18988

1.89

147.87

1.5

1.3

1.80

1.64

u/ml

0.21

732

5724

Oter anti-inflammatory and antirheumatic agents, non-steroids

2560

8174

1.90

147.54

1.3

1.2

1.02

2.17

u/ml

6.32

704

2148

Polycystic ovarian syndrome, consortium definition

13429

62352

1.34

147.17

1.4

1.3

1.30

1.48

u/ml

1.09

3788

17442

Disturbance of activity and attention

3079

19801

1.91

147.12

1.6

1.5

1.78

1.74

u/ml

0.05

768

5657

Obesity due to excess calories

8116

62225

1.44

146.82

1.4

1.3

1.47

1.60

u/ml

0.47

2372

17754

Diabetic retinopathy, excluding more controls

4079

15400

1.73

146.30

1.8

1.4

1.91

1.52

u/ml

1.01

1202

4177

Polyarthrosis

2945

16721

1.81

145.83

1.4

1.3

1.31

1.89

u/ml

2.38

847

4351

Urticaria

5330

38530

1.58

145.44

1.5

1.4

1.46

1.73

u/ml

0.92

1451

10835

Disorders of tooth development and eruption

2772

14034

1.86

144.94

1.4

1.3

1.22

1.77

u/ml

2.07

756

4195

Non-invasive ventilation

3721

21311

1.68

144.31

1.3

1.2

3.22

1.88

u/ml

2.07

419

6262

Extrapyramidal and movement disorders

5408

38844

1.54

143.74

1.4

1.3

1.66

1.69

u/ml

0.04

1364

10242

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9209

70290

1.39

142.18

1.4

1.3

1.56

1.61

u/ml

0.15

2202

19439

Covid-19 confirmed case

5492

39640

1.53

141.78

1.4

1.3

1.44

1.71

u/ml

1.04

1548

10621

Cardiovascular diseases (excluding rheumatic etc)

11868

54228

1.35

141.24

1.4

1.59

1.67

u/ml

0.26

3533

15642

Hyperkinetic disorders

3188

20859

1.86

139.86

1.6

1.5

1.95

1.75

u/ml

0.27

796

5912

Deforming dorsopathies

4343

30225

1.61

139.46

1.4

1.3

1.34

1.85

u/ml

1.99

1207

8110

Paracetamol or NSAID medication

2761

8403

1.84

139.05

1.4

1.90

2.28

u/ml

0.52

732

2089

Injuries to the thorax

6459

47870

1.46

138.78

1.4

1.3

1.86

1.74

u/ml

0.23

1641

12919

Special screening examination for other diseases and disorders

1917

11017

2.05

137.54

1.5

1.3

1.73

1.75

u/ml

0.01

854

3108

Any operation in hilmo

739

1335

3.34

137.19

1.4

1.2

1.35

1.93

u/ml

0.65

191

433

Papulosquamous disorders

5862

43132

1.50

136.87

1.4

1.3

1.69

1.67

u/ml

0.04

1600

11781

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8537

66055

1.39

136.25

1.4

1.3

1.60

1.61

u/ml

0.02

2042

18207

Viral Sepsis

3082

20071

1.75

135.96

1.4

1.3

2.00

1.86

u/ml

0.16

782

5222

Other heart diseases, wide

15287

76133

1.29

135.60

1.4

1.3

1.61

1.67

u/ml

0.24

4266

21502

Diabetic maculopathy

1956

10955

2.13

135.22

2.0

1.4

1.59

1.57

u/ml

0.03

674

3137

Implicit viral Sepsis

3073

20031

1.75

134.97

1.4

1.3

2.00

1.87

u/ml

0.16

779

5215

Other cataract

5806

31363

1.49

134.15

1.4

1.3

1.98

1.74

u/ml

0.54

1547

8309

Benign neoplasm: Ascending colon

1966

11541

2.03

133.78

1.3

1.76

u/ml

0.00

430

2954

Bipolar affective disorders

3288

22026

1.74

133.68

1.4

1.3

1.95

1.60

u/ml

0.58

846

6672

Sicca syndrome [Sjögren]

1488

8212

2.39

133.41

1.5

1.3

2.09

1.58

u/ml

0.66

426

2214

Iron deficiency

848

3988

3.81

132.61

1.7

1.4

0.94

1.66

u/ml

2.20

310

1140

Trochanteric bursitis

2300

14137

1.92

132.48

1.4

1.3

1.21

1.76

u/ml

2.32

631

3774

Disorders of lens

8887

42584

1.38

132.06

1.4

1.3

2.03

1.73

u/ml

0.99

2342

11655

Hypertension

12154

55069

1.32

131.83

1.4

1.3

1.62

1.68

u/ml

0.21

3553

15714

Paralytic ileus and intestinal obstruction

3159

20621

1.69

131.03

1.3

1.89

1.90

u/ml

0.01

845

5509

Hypertensive diseases

12156

55141

1.32

130.72

1.4

1.3

1.62

1.68

u/ml

0.21

3556

15732

External causes of morbidity and mortality

11019

43777

1.34

130.63

1.4

1.3

1.67

1.57

u/ml

0.33

2989

13081

Hyperlipidaemia, other/unspecified

4890

31312

1.53

130.27

1.3

1.22

1.83

u/ml

5.19

1395

8135

Endometriosis of pelvic peritoneum

2842

16855

1.82

129.90

1.4

1.3

1.20

1.64

u/ml

1.85

845

4787

Allergic asthma (mode), excluding more controls

4202

28821

1.61

129.59

1.4

1.3

1.75

1.74

u/ml

0.01

1160

8506

Chronic pancreatitis

1695

9586

2.11

129.37

1.5

1.3

2.46

2.08

u/ml

0.31

432

2526

Benign neoplasm of other and ill-defined parts of digestive system

2578

16404

1.84

129.18

1.4

1.3

1.51

1.73

u/ml

0.35

725

4307

Fracture of lumbar spine and pelvis

3094

20300

1.72

129.16

1.4

1.3

1.55

1.74

u/ml

0.40

733

5236

Propionic acid derivatives

4256

14588

1.60

128.08

1.4

1.63

2.21

u/ml

1.46

1139

3705

Restless leg syndrome

2324

14558

1.92

127.68

1.4

1.3

1.45

1.65

u/ml

0.29

636

3985

Allergic asthma (mode)

4203

28916

1.60

127.61

1.4

1.3

1.75

1.74

u/ml

0.01

1161

8536

Arthrosis

10137

43686

1.35

127.59

1.3

1.58

1.78

u/ml

0.81

2926

12326

Thyroiditis, ILD-related definition

2097

12904

2.02

127.41

1.6

1.4

1.58

1.62

u/ml

0.06

588

3648

Dipeptidyl peptidase 4 (DPP-4) inhibitors

7077

42081

1.42

125.62

1.3

1.56

1.80

u/ml

0.76

1814

10863

Enthesopathies of lower limb, excluding foot

3490

23769

1.66

125.34

1.4

1.3

1.18

1.89

u/ml

4.55

918

6673

Adhesive capsulitis of shoulder

2342

14581

1.85

124.98

1.5

1.3

1.50

2.03

u/ml

1.38

716

3946

Undetermined asthma, excluding more controls

2129

12986

1.93

124.98

1.4

1.3

1.15

1.88

u/ml

2.28

549

3609

Allergic rhinitis

5728

42459

1.50

123.64

1.5

1.4

1.42

1.73

u/ml

1.22

1603

12117

Obesity, other/unspecified

5726

42846

1.49

123.49

1.4

1.3

1.52

1.60

u/ml

0.18

1478

12553

2495

16037

1.85

123.04

1.5

1.3

1.06

1.68

u/ml

3.41

593

4556

Undetermined asthma

2129

13057

1.92

122.45

1.4

1.3

1.15

1.88

u/ml

2.31

549

3647

Abnormal serum enzyme levels

3520

23062

1.62

122.38

1.4

1.3

1.54

1.98

u/ml

1.45

906

5950

Other disorders of glucose regulation and pancreatic internal secretion

1395

7661

2.30

122.26

1.8

1.4

2.19

1.78

u/ml

0.38

407

2033

Benign neoplasm: Sigmoid colon

2512

16055

1.80

120.78

1.3

1.63

1.81

u/ml

0.26

597

4174

Persistent mood disorders

3029

20272

1.72

120.68

1.4

1.3

1.23

1.62

u/ml

1.16

727

5801

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

5360

39826

1.50

120.52

1.4

1.3

1.48

1.72

u/ml

1.02

1427

10942

Eating disorder

2062

13075

2.10

120.50

1.7

1.4

1.18

1.54

u/ml

1.18

571

3779

Phobic anxiety disorders

2640

17330

1.83

120.10

1.5

1.4

1.49

1.75

u/ml

0.50

652

5173

Glucagon-like peptide-1 (GLP-1) analogues

4475

32209

1.54

119.52

1.3

1.23

1.76

u/ml

2.98

1349

9009

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

4475

32209

1.54

119.52

1.3

1.23

1.76

u/ml

2.98

1349

9009

Injuries to the knee and lower leg

19622

90139

1.24

119.48

1.4

1.3

1.81

1.63

u/ml

0.94

5231

25114

Post-traumatic stress disorder

1878

11520

2.10

119.42

1.5

1.4

1.21

1.52

u/ml

0.76

478

3553

Disorders of vestibular function (Vertigo)

6666

49569

1.42

119.42

1.3

1.60

1.63

u/ml

0.05

1625

13275

Implicit bacterial Sepsis, including avohilmo

5971

37035

1.44

118.87

1.4

1.3

1.79

1.77

u/ml

0.02

1386

9608

Other and unspecified disorders of vitreous body

5805

42585

1.46

118.18

1.4

1.3

1.70

1.65

u/ml

0.09

1549

11000

Cervicocranial syndrome

1731

10182

2.05

118.09

1.4

1.3

1.03

1.82

u/ml

2.77

545

2755

Infections of the skin and subcutaneous tissue

9337

73431

1.34

117.04

1.4

1.3

1.85

1.70

u/ml

0.44

2456

20573

Impingement syndrome of shoulder

3111

20908

1.66

117.00

1.4

1.3

1.84

1.93

u/ml

0.12

752

5637

Crohn disease

2184

13771

1.90

116.99

1.4

1.3

0.91

1.79

u/ml

8.40

585

3917

Anti-inflammatory and antirheumatic products, non-steroids

4195

14595

1.57

116.90

1.4

1.67

2.21

u/ml

1.27

1101

3705

Hernia

14215

78292

1.27

116.83

1.3

1.76

1.66

u/ml

0.34

3717

21942

Eating disorders

2276

14762

1.96

116.77

1.7

1.4

1.17

1.50

u/ml

1.15

641

4259

Unspecified/other endometriosis

1832

10910

2.06

116.29

1.4

1.3

1.11

1.65

u/ml

1.82

522

3215

Fracture of rib(s), sternum and thoracic spine

4019

28372

1.56

116.07

1.4

1.3

1.76

1.72

u/ml

0.05

986

7536

Injury, poisoning and certain other consequences of external causes

9045

35600

1.36

115.87

1.4

1.3

1.71

1.59

u/ml

0.33

2509

10329

Other diseases of the digestive system

3981

28002

1.55

115.57

1.4

1.3

1.75

1.24

u/ml

1.51

998

7048

Percutaneous Coronary Intervention

10862

53220

1.32

115.37

1.4

1.3

1.41

1.82

u/ml

3.60

3236

13848

Emotionally unstable personality disorder

2453

16140

1.87

115.31

1.5

1.4

1.92

1.56

u/ml

0.51

569

4863

Diabetic retinopathy

4748

21402

1.54

114.94

1.7

1.4

1.83

1.54

u/ml

0.81

1367

5940

Transport accidents

7650

49590

1.38

114.81

1.4

1.3

2.02

1.52

u/ml

1.68

2049

14901

Gonarthrosis

8571

37849

1.36

113.26

1.3

1.58

1.83

u/ml

0.94

2415

10498

Thyrotoxicosis, other and/or unspecified

3204

22030

1.67

112.91

1.4

1.3

1.77

1.68

u/ml

0.15

875

5993

Other menopausal disorders

4122

16259

1.59

112.35

1.3

1.14

1.73

u/ml

2.58

1188

4442

Senile cataract

7770

36607

1.37

111.84

1.4

1.3

2.02

1.73

u/ml

0.83

1969

9828

Diseases of inner ear

7602

56918

1.37

111.76

1.3

1.58

1.63

u/ml

0.11

1850

15357

Tinnitus

3411

23751

1.62

110.38

1.4

1.3

1.42

1.77

u/ml

0.90

812

6467

Trigger finger

2170

13718

1.83

110.24

1.5

1.3

1.72

1.97

u/ml

0.35

607

3795

Other eating disorders

1229

6973

2.57

109.76

1.7

1.4

1.32

1.68

u/ml

0.65

343

1933

Emergency coronary revascularization (for ACS)

11493

56487

1.29

109.58

1.4

1.3

1.44

1.80

u/ml

2.83

3403

14636

Coronary revascularization (ANGIO or CABG)

10821

53252

1.31

109.13

1.4

1.3

1.42

1.82

u/ml

3.51

3232

13855

Asthma and allergy

2526

16503

1.78

109.08

1.5

1.4

1.43

1.76

u/ml

0.79

682

4789

Other (not insulin) diabetes medications

14676

71921

1.26

108.88

1.3

1.51

1.64

u/ml

0.57

4139

19925

Artrosis, including avohilmo

12065

54001

1.29

108.78

1.3

1.54

1.72

u/ml

0.81

3524

15204

Deviated nasal septum

4271

30786

1.51

108.63

1.3

1.65

1.85

u/ml

0.40

1138

8795

Mycoses

4193

30388

1.54

108.52

1.4

1.3

2.04

1.71

u/ml

0.62

1112

8421

Asthma and allergy, excluding more controls

2526

16545

1.77

108.03

1.5

1.4

1.43

1.78

u/ml

0.84

681

4790

Asthma, hospital admissions 3, pneumonia

5065

37507

1.46

107.74

1.4

1.3

1.75

1.80

u/ml

0.07

1334

9811

Asthma-related pneumonia or sepsis

5065

37507

1.46

107.74

1.4

1.3

1.75

1.80

u/ml

0.07

1334

9811

Asthma-related pneumonia

5052

37397

1.46

107.73

1.4

1.3

1.75

1.80

u/ml

0.08

1331

9785

Atopic dermatitis, strict definition

5578

41683

1.47

107.60

1.5

1.4

1.87

1.62

u/ml

0.68

1533

11971

Implicit bacterial Sepsis

5274

33616

1.45

107.22

1.4

1.3

1.80

1.82

u/ml

0.04

1211

8656

Internal derangement of knee

5398

40151

1.44

106.64

1.3

1.51

1.82

u/ml

0.84

1486

11289

All kidney diseases

15764

89206

1.24

106.57

1.4

1.3

1.62

1.65

u/ml

0.11

4187

24921

Autoimmune hepatitis, wide definition

797

3780

2.85

106.55

1.4

1.2

1.19

1.36

u/ml

0.24

187

1022

Diseases of male genital organs

5857

21911

1.43

106.36

1.3

1.87

2.21

u/ml

1.01

1615

6034

Injuries to the wrist and hand

16593

93389

1.24

106.32

1.4

1.3

1.60

1.67

u/ml

0.26

4381

26032

Benign neoplasm: Rectum

2334

15118

1.76

105.94

1.3

1.75

1.73

u/ml

0.02

528

3932

Infections with a predominantly sexual mode of transmission, including avohilmo

7419

53748

1.39

105.93

1.4

1.67

1.55

u/ml

0.31

1935

16018

Other bacterial intestinal infections

2521

16582

1.72

105.92

1.4

1.3

1.61

1.82

u/ml

0.29

597

4442

Chronic kidney disease

3714

25159

1.54

105.61

1.4

1.3

2.10

1.88

u/ml

0.32

920

6297

Diseases of tongue

950

4770

2.51

105.59

1.4

1.3

1.31

1.76

u/ml

0.67

265

1331

Ischemic heart diseases

11486

55938

1.29

105.48

1.4

1.3

1.44

1.79

u/ml

2.73

3417

14708

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

3588

25839

1.62

104.78

1.5

1.4

1.12

1.45

u/ml

1.38

1021

7526

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

15819

84533

1.24

104.43

1.4

1.3

1.61

1.66

u/ml

0.19

4404

23449

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2847

19446

1.69

104.42

1.4

1.3

1.34

1.80

u/ml

1.30

743

5578

Substance abuse, excluding more controls

7929

52330

1.35

104.14

1.4

1.3

1.82

1.74

u/ml

0.17

1973

15311

Female genital prolapse

4225

16894

1.54

103.22

1.3

1.32

1.75

u/ml

1.50

1185

4608

Mouth breathing

5450

41279

1.44

103.21

1.4

1.3

1.67

1.83

u/ml

0.40

1487

11192

Injuries to the head

18205

92411

1.22

103.12

1.4

1.3

1.73

1.65

u/ml

0.33

4751

25842

Adenomyosis (Endometriosis of uterus)

2058

13106

1.85

103.07

1.4

1.3

1.16

1.81

u/ml

2.75

540

3572

Diseases of salivary glands

5029

37884

1.46

102.37

1.4

1.3

1.37

1.68

u/ml

1.01

1349

10533

Hypo-osmolality and hyponatraemia

2295

14733

1.74

102.25

1.4

1.3

1.65

1.90

u/ml

0.39

656

3763

Other disorders of ear

13731

74211

1.26

101.96

1.4

1.3

1.58

1.71

u/ml

0.60

3626

20358

Other and unspecified effects of external causes

4634

34621

1.50

101.84

1.4

1.67

1.70

u/ml

0.05

1264

9853

Tonsillectomy and adenotomy

10227

58305

1.31

101.75

1.4

1.50

1.64

u/ml

0.45

2751

17343

GI-bleeding

3884

27808

1.51

101.53

1.4

1.3

1.60

1.24

u/ml

1.03

988

6997

Ulcerative colitis (strict definition, require KELA)

2668

18099

1.70

101.51

1.4

1.3

1.38

1.80

u/ml

1.01

694

5217

Benign neoplasm: Rectum, anus and anal canal

2562

17072

1.69

101.37

1.3

1.69

1.75

u/ml

0.08

575

4439

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

2603

17583

1.72

101.35

1.4

1.3

1.39

1.78

u/ml

0.92

679

5058

Other sleep disorders

1731

10587

1.93

101.32

1.4

1.3

1.47

2.15

u/ml

1.35

569

2934

Gonarthrosis [arthrosis of knee](FG)

10145

47227

1.30

100.83

1.3

1.61

1.77

u/ml

0.54

2831

12967

Chronic laryngitis and laryngotracheitis

2028

12905

1.82

100.65

1.4

1.3

1.35

1.78

u/ml

0.64

365

3648

Other CVD (FINNGEN)

1555

6917

1.98

100.12

1.4

1.3

1.53

2.04

u/ml

0.57

368

1694

Neoplasms

13246

57936

1.27

100.11

1.4

1.52

1.76

u/ml

1.30

3674

17064

Radiculopathy

2068

13133

1.78

99.73

1.4

1.3

1.60

2.00

u/ml

0.60

590

3414

Other disorders of eyelid

5751

41470

1.41

99.55

1.3

1.45

1.69

u/ml

0.91

1439

10764

Rheumatoid arthritis

4341

28161

1.48

99.17

1.3

1.12

1.78

u/ml

5.28

1134

7637

Continuous positive airway pressure

2326

12539

1.71

98.68

1.3

2.11

2.20

u/ml

0.08

397

3437

Female infertility

4957

22279

1.49

98.62

1.4

1.3

1.36

1.59

u/ml

0.76

1602

6307

Renal failure

5685

36835

1.40

98.33

1.4

1.3

1.80

1.81

u/ml

0.03

1359

9363

Exclusions for E4_PCOS_BROAD

2785

19195

1.68

98.14

1.5

1.4

1.25

1.90

u/ml

3.33

841

5235

Other heart diseases

7707

39717

1.36

97.99

1.4

1.56

1.80

u/ml

0.89

2199

11371

Fibroblastic disorders

2835

19295

1.61

97.76

1.4

1.3

1.86

1.99

u/ml

0.17

676

5175

Other general symptoms and signs

1032

5543

2.44

97.58

1.6

1.4

1.93

1.86

u/ml

0.04

312

1502

Coxarthrosis

6269

31051

1.38

96.70

1.3

1.62

1.87

u/ml

0.78

1637

8328

Pollen allergy

3630

26137

1.58

96.65

1.5

1.4

1.36

1.77

u/ml

1.44

920

7424

Vascular disorders of the intestines

822

3968

2.46

96.38

1.4

1.2

1.98

1.75

u/ml

0.15

191

1013

Gastroduodenal ulcer

2851

19343

1.59

96.25

1.3

1.86

1.85

u/ml

0.01

735

5090

Ulcerative colitis (strict definition, all Crohn cases excluded)

2284

15181

1.75

96.06

1.4

1.3

1.48

1.80

u/ml

0.58

605

4353

Zoster [herpes zoster], including avohilmo

7398

56790

1.35

95.66

1.3

1.57

1.64

u/ml

0.15

2003

15070

L04AA Selective immunosuppressants

3380

24232

1.58

95.21

1.4

1.3

1.24

1.73

u/ml

1.89

917

6732

Hard cardiovascular diseases

11713

57332

1.27

95.02

1.4

1.3

1.38

1.78

u/ml

3.75

3388

15313

Obsessive-compulsive disorder

1433

8677

2.12

94.97

1.6

1.4

1.73

1.50

u/ml

0.25

361

2567

Non-allergic asthma (mode), excluding more controls

2802

19093

1.62

94.63

1.4

1.3

1.38

1.93

u/ml

1.89

791

5217

Biological medication for rheuma

2993

21123

1.63

94.35

1.4

1.27

1.74

u/ml

1.63

902

6099

Other disorders of bladder

1500

8947

1.93

93.50

1.4

1.3

1.91

1.82

u/ml

0.08

380

2369

Other and unspecified urticaria

3261

23402

1.59

93.24

1.4

1.39

1.73

u/ml

0.87

862

6550

Female infertility, cervical, vaginal, other or unspecified origin

4532

21660

1.49

93.18

1.4

1.3

1.29

1.57

u/ml

1.07

1446

6141

Injuries to the elbow and forearm

11561

82779

1.27

92.96

1.4

1.3

2.00

1.62

u/ml

1.73

2936

22840

Disorders of sclera, cornea, iris and ciliary body

8259

66859

1.32

92.74

1.4

1.3

1.73

1.62

u/ml

0.30

2405

18531

Monoamine oxidase A inhibitors

1624

9984

1.90

92.31

1.4

1.3

1.26

1.74

u/ml

1.23

428

2759

Spondylolisthesis/Spondylolysis

2495

16875

1.66

92.14

1.4

1.3

1.12

1.98

u/ml

3.92

695

4513

Benign neoplasm: Stomach

1371

8119

2.04

92.10

1.4

1.3

1.76

1.52

u/ml

0.28

366

2115

Viral hepatitis, IBD co-morbidity

786

3816

2.48

91.95

1.4

1.2

2.21

2.17

u/ml

0.02

158

1157

Stomatitis and related lesions

3173

22670

1.59

91.83

1.4

1.60

1.70

u/ml

0.18

833

6270

Abrasion of teeth

5496

42583

1.41

91.54

1.4

1.3

1.50

1.60

u/ml

0.24

1456

11992

Non-allergic asthma (mode)

2803

19232

1.61

91.42

1.4

1.3

1.38

1.89

u/ml

1.74

791

5268

Hypoglycaemia, other or unspecified

1096

6120

2.25

91.37

1.8

1.4

2.00

1.64

u/ml

0.30

325

1645

Thyrotoxicosis

3883

28669

1.51

91.31

1.4

1.3

1.72

1.64

u/ml

0.16

1058

7928

Bleeding

11512

67137

1.26

91.22

1.4

1.3

1.84

1.71

u/ml

0.38

3014

17991

Intracranial injury

8903

67648

1.30

90.93

1.4

1.3

1.74

1.71

u/ml

0.08

2381

18494

Herpesviral [herpes simplex] infections, including avohilmo

4376

33011

1.48

90.82

1.4

1.3

1.18

1.61

u/ml

2.44

1248

9435

Acne, including avohilmo

4629

28582

1.49

90.29

1.5

1.4

1.48

1.62

u/ml

0.39

1306

8239

Major coronary heart disease event

11314

56125

1.27

90.24

1.4

1.3

1.46

1.80

u/ml

2.46

3332

14649

Mucosal proctocolitis

2020

13262

1.78

89.83

1.4

1.3

0.99

1.73

u/ml

5.36

511

3833

All chronic kidney diseases

7411

47096

1.33

89.72

1.4

1.3

1.72

1.80

u/ml

0.21

1974

12399

Other obstetric conditions, not elsewhere classified

6506

32672

1.40

89.15

1.4

1.09

1.48

u/ml

3.27

2007

10003

Benign neoplasm: Caecum

1429

8601

1.97

89.01

1.4

1.3

1.76

1.70

u/ml

0.04

347

2194

Recurrent aphthous stomatitis , including avohilmo

2335

15889

1.71

88.87

1.5

1.4

1.54

1.70

u/ml

0.26

627

4290

Crohn's disease of small intestine

1192

6928

2.17

88.84

1.4

1.3

0.83

1.71

u/ml

4.50

347

1976

Viral and other specified intestinal infections

3826

27645

1.51

88.73

1.6

1.4

1.83

1.80

u/ml

0.03

1106

7604

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

6395

32016

1.41

88.72

1.4

1.09

1.45

u/ml

2.81

1973

9805

Ulcerative colitis, NAS

2148

14317

1.74

88.50

1.4

1.3

1.43

1.82

u/ml

0.72

556

4059

Bacterial Sepsis

6020

38709

1.37

88.46

1.4

1.3

1.91

1.78

u/ml

0.25

1400

10066

Heart failure, not strict

9649

53169

1.29

88.04

1.4

1.3

1.86

1.74

u/ml

0.33

2436

14100

Other enthesopathy of foot (+metatarsalgia)

1649

10361

1.88

87.98

1.4

1.3

1.32

1.79

u/ml

0.97

413

2823

Bacterial intestinal infections, IBD co-morbidities

2504

17118

1.64

87.79

1.4

1.3

1.53

1.77

u/ml

0.35

585

4565

Fall on same level involving ice and snow

8826

72334

1.30

87.68

1.4

1.3

1.76

1.61

u/ml

0.44

2307

19759

Meniscus derangement

7293

38448

1.33

87.62

1.3

1.47

1.82

u/ml

1.68

1950

10710

Lichen simplex chronicus and prurigo

978

5330

2.30

87.55

1.5

1.3

2.03

1.60

u/ml

0.47

251

1422

Postmenopausal bleeding

3532

13221

1.54

87.20

1.3

1.46

1.79

u/ml

0.72

869

3440

Inflammatory diseases of prostate (prostatitis)

1352

7913

1.92

87.20

1.3

2.42

2.15

u/ml

0.21

336

2146

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

10724

81699

1.27

87.13

1.4

1.58

1.65

u/ml

0.25

2911

23283

Adverse effects, not elsewhere classified

3283

23896

1.56

86.53

1.5

1.4

1.69

1.68

u/ml

0.00

871

6762

STROKE

7433

39981

1.33

86.15

1.3

1.26

1.77

u/ml

4.19

1979

10551

Persons encountering health services for specific procedures, not carried out

1480

9169

1.96

85.62

1.5

1.3

1.29

1.74

u/ml

0.56

260

2582

Other shoulder lesions

1482

9117

1.92

85.53

1.4

1.3

1.26

1.89

u/ml

1.10

364

2529

Other noninflammatory disorders of vulva and perineum

1645

10454

1.88

85.43

1.4

1.3

1.65

1.77

u/ml

0.11

443

2958

Ulcer of lower limb, not elsewhere classified

1773

11275

1.78

85.39

1.5

1.3

1.65

1.79

u/ml

0.21

414

2900

Primary biliary cholangitis, wide definition

440

1801

3.78

85.21

1.5

1.3

0.81

1.29

u/ml

0.81

111

462

Diseases of arteries, arterioles and capillaries (FINNGEN)

3067

14871

1.55

85.11

1.4

1.3

1.54

1.89

u/ml

0.75

774

4023

Atrial fibrillation and flutter with reimbursement

3209

14292

1.54

84.82

1.3

1.85

1.86

u/ml

0.02

862

3853

Benign neoplasm: Transverse colon

1409

8554

1.93

84.49

1.4

1.3

1.53

1.90

u/ml

0.40

341

2209

4787

32739

1.41

84.45

1.3

1.89

1.73

u/ml

0.28

1185

7969

Uterine polyps

4126

17924

1.48

83.65

1.3

1.23

1.72

u/ml

2.02

1054

4916

Other neurological diseases

9709

62214

1.27

83.54

1.4

1.3

1.48

1.69

u/ml

0.92

2587

16510

Skin changes due to chronic exposure to nonionizing radiation

4469

30522

1.42

83.25

1.3

1.92

1.66

u/ml

0.45

1105

7367

Metatarsalgia

1514

9445

1.90

83.20

1.4

1.3

1.41

1.70

u/ml

0.46

369

2577

Implicit fungal Sepsis, including avohilmo

1112

6405

2.14

83.19

1.5

1.3

1.69

1.68

u/ml

0.01

254

1681

Brachial plexus disorders

1559

9882

1.90

82.68

1.4

1.3

1.31

1.75

u/ml

0.90

583

2912

Lateral epicondylitis

1904

12487

1.74

82.44

1.4

1.3

1.91

1.99

u/ml

0.07

584

3541

Disorders of parathyroid gland

2710

18803

1.58

82.35

1.4

1.3

1.27

1.61

u/ml

0.95

701

4755

Abnormal results of function studies

1417

8758

1.95

82.34

1.5

1.3

1.41

1.89

u/ml

0.80

387

2361

Vitreous haemorrhage

1372

8331

1.93

82.23

1.7

1.3

2.02

1.72

u/ml

0.32

405

2204

Use of pramipexole

2885

20531

1.56

82.22

1.4

1.3

1.57

1.74

u/ml

0.35

789

5375

Bullous disorders

841

4444

2.38

82.12

1.7

1.3

4.44

1.67

u/ml

3.06

267

1161

Erosion of teeth , including avohilmo

4502

34577

1.44

81.99

1.5

1.4

1.50

1.64

u/ml

0.33

1166

9934

Actinic keratosis

4303

29431

1.43

81.96

1.3

1.87

1.68

u/ml

0.32

1074

7074

Unspecified fall

7548

60117

1.31

81.83

1.4

1.3

2.03

1.70

u/ml

0.94

1670

16217

Psoriasis

3980

29880

1.46

81.55

1.4

1.3

1.73

1.72

u/ml

0.01

1087

8303

Abnormal involuntary movements

1966

13081

1.73

81.07

1.4

1.3

1.59

1.76

u/ml

0.20

505

3458

Other acute lower respiratory infections

7985

62069

1.30

81.06

1.4

1.41

1.74

u/ml

1.83

2059

16875

Necrosis of pulp, including avohilmo

9199

75480

1.28

80.95

1.4

1.3

1.58

1.63

u/ml

0.14

2669

21545

Hallux valgus (acquired)

4610

25073

1.42

80.66

1.3

1.47

1.83

u/ml

1.07

1127

6885

13955

69685

1.22

80.24

1.4

1.3

1.74

1.70

u/ml

0.14

3599

19457

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

13955

69685

1.22

80.24

1.4

1.3

1.74

1.70

u/ml

0.14

3599

19457

Other or unspecified ileus, impaction or obstruction

2061

13654

1.65

79.78

1.3

1.76

1.95

u/ml

0.22

553

3598

Coxarthrosis [arthrosis of hip](FG)

6836

37472

1.32

79.78

1.3

1.58

1.80

u/ml

0.68

1755

9892

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

6873

34680

1.33

79.40

1.3

1.63

1.68

u/ml

0.10

2064

10154

Candidiasis

2249

15514

1.67

79.37

1.4

1.3

2.23

1.56

u/ml

0.94

554

4324

Hyperplasia of prostate

3330

13327

1.49

79.35

1.3

1.2

2.01

2.26

u/ml

0.44

878

3602

Renal tubulo-interstitial diseases

13225

82749

1.23

79.32

1.4

1.3

1.58

1.65

u/ml

0.27

3435

22774

Diseases of middle ear and mastoid

9616

65520

1.27

79.28

1.4

1.90

1.58

u/ml

1.23

2578

18738

Other viral diseases, including avohilmo

6479

51673

1.34

79.20

1.4

1.42

1.71

u/ml

1.16

1877

14695

Abnormalities of gait and mobility

1590

10101

1.81

79.07

1.4

1.3

1.54

1.85

u/ml

0.53

318

2474

Hypotension

1998

13229

1.67

78.85

1.3

1.44

1.72

u/ml

0.37

475

3271

Chronic hepatitis, not elsewhere classified

610

2973

2.89

78.67

1.6

1.3

1.27

1.60

u/ml

0.50

140

807

Other and unspecified nerve root and plexus disorders, also in other diseases

2932

21135

1.54

77.78

1.4

1.3

1.92

1.76

u/ml

0.18

634

5932

Other CVD

2322

15912

1.60

77.62

1.3

1.41

1.79

u/ml

0.67

542

3969

Lichen ruber planus, wide definition including periferal and oral lichen planus

3145

23005

1.52

77.48

1.4

1.3

1.67

1.75

u/ml

0.13

877

6150

Acute renal failure

2568

17951

1.56

77.46

1.4

1.3

1.76

1.92

u/ml

0.19

600

4577

Allergic contact dermatitis

2167

14925

1.68

77.17

1.5

1.3

1.66

1.60

u/ml

0.09

570

4266

Childhood asthma (age<16), excluding more controls

2684

14954

1.60

77.04

1.5

1.4

1.96

1.78

u/ml

0.27

764

4428

Benign paroxysmal vertigo

3998

30292

1.44

76.91

1.4

1.3

1.62

1.70

u/ml

0.15

981

8067

Other inflammatory liver diseases

988

5640

2.17

76.45

1.4

1.3

1.10

1.58

u/ml

1.35

235

1535

Childhood asthma (age<16)

2685

14984

1.60

76.44

1.5

1.4

1.96

1.78

u/ml

0.27

764

4435

Disorders of mineral metabolism

1243

7525

1.96

76.31

1.4

1.3

1.02

1.81

u/ml

2.61

344

2006

Thyrotoxicosis with diffuse goitre

2210

15307

1.66

76.10

1.4

1.3

1.86

1.54

u/ml

0.54

621

4248

Acute bronchitis

5805

45191

1.34

75.86

1.4

1.3

1.33

1.74

u/ml

2.05

1491

12202

Inflammatory disease of uterus

2504

17925

1.63

75.56

1.4

1.3

1.20

1.53

u/ml

0.91

680

5278

Other maternal disorders predominantly related to pregnancy

9847

51799

1.28

75.43

1.4

1.3

1.46

1.47

u/ml

0.03

3082

14510

Poisoning by drugs, medicaments and biological substances

3844

29205

1.46

75.36

1.4

1.47

1.65

u/ml

0.40

936

8497

Polyp of the female genital tract

4367

18806

1.43

75.33

1.3

1.26

1.69

u/ml

1.66

1104

5171

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

13860

75201

1.21

74.97

1.3

1.51

1.67

u/ml

0.78

3820

20920

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4925

38358

1.40

74.88

1.5

1.4

1.61

u/ml

0.01

1271

11194

Tumor necrosis factor alpha inhibitors

2636

18968

1.59

74.54

1.4

1.33

1.75

u/ml

1.16

808

5492

Gastric ulcer

1940

12889

1.65

74.50

1.3

1.46

1.88

u/ml

0.69

498

3379

Viral infections characterized by skin and mucous membrane lesions

6232

50106

1.33

74.35

1.4

1.77

1.75

u/ml

0.05

1706

13731

Colonic or urogenital fistula

3670

27602

1.45

74.20

1.4

1.3

1.22

1.78

u/ml

2.67

972

7701

Other inflammation of eyelid

2107

14487

1.66

74.10

1.4

1.3

1.43

1.77

u/ml

0.73

489

3909

Amenorrhoea

1339

8471

1.96

74.05

1.6

1.4

1.98

1.78

u/ml

0.17

410

2427

Pain associated with micturition

1806

12064

1.73

73.68

1.4

1.3

1.69

1.70

u/ml

0.01

454

3189

Iron deficiency anaemia secondary to blood loss (chronic)

2043

13866

1.64

73.47

1.4

1.3

1.54

1.68

u/ml

0.19

523

3631

Maternal care for other conditions predominantly related to pregnancy

3847

28791

1.47

73.43

1.4

1.3

1.15

1.39

u/ml

1.31

1213

8632

Prurigo nodularis

429

1852

3.37

73.09

1.5

1.3

2.18

1.45

u/ml

0.53

100

511

Gout

2830

17289

1.50

72.95

1.3

1.98

2.10

u/ml

0.14

670

4362

Paroxysmal tachycardia

3273

20052

1.48

72.67

1.3

1.32

1.79

u/ml

1.87

898

5482

Excessive earwax

8787

66279

1.27

72.60

1.3

1.47

1.74

u/ml

1.46

2624

17294

Exclusions for E4_PCOS_CONSORTIUM

12406

66394

1.23

72.58

1.4

1.28

1.59

u/ml

2.39

3400

18763

Type 2 diabetes, definitions combined

13778

68899

1.21

72.45

1.3

1.48

1.64

u/ml

0.74

3899

19104

Atrial fibrillation and flutter

4055

19742

1.42

72.31

1.3

1.66

1.77

u/ml

0.20

1115

5551

Type 2 diabetes, strict (exclude DM1)

13819

69141

1.21

72.20

1.3

1.48

1.64

u/ml

0.75

3908

19163

Primary biliary cholangitis (PBC)

399

1683

3.55

72.10

1.5

1.2

0.68

1.37

u/ml

1.28

437

Psychotic depression

901

5038

2.15

72.09

1.4

1.3

0.97

1.72

u/ml

2.78

229

1449

Other disorders of veins

5851

46145

1.34

72.05

1.3

1.49

1.59

u/ml

0.22

1382

12581

Diseases of external ear

4996

39308

1.37

72.04

1.4

1.3

1.52

1.76

u/ml

0.73

1180

10686

Poisoning by medicine

3496

26396

1.47

71.90

1.4

1.54

1.71

u/ml

0.32

864

7696

Alcoholic liver disease

1184

7113

1.91

71.90

1.4

1.3

3.64

1.97

u/ml

1.39

232

1973

Convulsions, not elsewhere classified

3431

25295

1.46

71.58

1.5

1.4

2.17

1.91

u/ml

0.38

847

6897

Social phobias

1633

10851

1.81

71.58

1.5

1.4

1.50

1.60

u/ml

0.11

386

3237

Injuries to the shoulder and upper arm

12784

84702

1.22

71.48

1.4

1.3

1.83

1.67

u/ml

0.56

3354

23283

Dysplasia of cervi uteri

3874

20716

1.45

71.30

1.4

1.3

1.48

1.59

u/ml

0.20

1150

5943

Other protozoal intestinal diseases, including avohilmo

466

2149

3.33

71.25

1.5

1.3

1.45

1.72

u/ml

0.15

106

577

Mixed and other personality disorders

1326

8400

1.92

71.25

1.5

1.3

2.01

1.63

u/ml

0.30

305

2535

Sensorineural hearing loss

9763

54482

1.25

70.99

1.3

1.60

1.72

u/ml

0.43

2607

14448

Oesophageal varices

591

2916

2.60

69.93

1.4

1.3

3.79

1.66

u/ml

0.97

108

756

Hypokalaemia

1646

10829

1.73

69.82

1.4

1.3

1.20

1.74

u/ml

1.59

407

2852

Periodontitis

14765

81704

1.20

69.62

1.3

1.58

1.65

u/ml

0.26

3816

23046

Other disorders of eye and adnexa

2253

15941

1.62

69.59

1.5

1.4

1.24

1.70

u/ml

1.62

525

4458

Injuries to the hip and thigh

6410

46454

1.31

69.54

1.3

1.69

1.70

u/ml

0.02

1621

12189

Injuries to the neck

3561

27058

1.45

68.75

1.4

1.3

1.39

1.73

u/ml

0.98

976

7739

Degeneration of macula and posterior pole

5521

33769

1.33

68.71

1.3

1.86

1.68

u/ml

0.36

1351

8230

Conductive and sensorineural hearing loss

10487

58842

1.23

68.63

1.3

1.57

1.70

u/ml

0.54

2828

15785

ILD medications: azathioprine

2220

15637

1.60

68.63

1.4

1.31

1.85

u/ml

1.80

592

4355

Chronic periodontitis, including avohilmo

14723

81646

1.20

68.48

1.3

1.56

1.65

u/ml

0.41

3806

23021

Elevated blood glucose level

1226

7622

1.90

68.39

1.7

1.3

2.68

1.86

u/ml

0.80

307

2033

Other abnormal uterine and vaginal bleeding

3337

17892

1.47

68.34

1.4

1.3

1.32

1.67

u/ml

0.95

821

4877

Blepharochalasis

3664

27837

1.43

68.22

1.3

1.34

1.73

u/ml

1.71

932

7186

Ganglion

3116

23171

1.48

68.17

1.4

1.3

1.72

1.81

u/ml

0.14

879

6645

Other diseases of stomach and duodenum

854

4774

2.13

67.98

1.5

1.3

1.48

1.65

u/ml

0.20

197

1271

Abnormal findings on diagnostic imaging of lung

5774

43831

1.32

67.71

1.3

1.77

1.72

u/ml

0.10

1357

11412

Type 2 diabetes, definitions combined, including avohilmo

13840

69155

1.20

67.64

1.3

1.49

1.64

u/ml

0.67

3920

19187

Azathioprine

2220

15683

1.60

67.57

1.4

1.31

1.87

u/ml

1.87

592

4361

Persons with potential health hazards related to communicable diseases

6488

52765

1.32

67.42

1.4

1.23

1.68

u/ml

3.11

2553

14773

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

4862

38668

1.37

67.29

1.4

1.38

1.58

u/ml

0.53

1258

11414

Vitamin B12 deficiency anaemia

1223

7524

1.84

67.00

1.4

1.3

2.09

1.50

u/ml

0.55

271

1934

Conjunctivitis (acute, non atopic)

4438

34703

1.39

66.82

1.4

1.90

1.81

u/ml

0.15

1168

9620

Other hearing loss

3274

23614

1.44

66.77

1.3

1.54

1.82

u/ml

0.74

777

5917

Endometriosis of ovary

2535

17273

1.55

66.60

1.4

1.3

1.10

1.65

u/ml

2.81

700

4821

Other viral diseases, not elsewhere classified, including avohilmo

4408

34487

1.39

65.81

1.4

1.36

1.78

u/ml

1.69

1283

9635

Ischaemic heart disease, wide definition

9635

49907

1.24

65.68

1.4

1.3

1.51

1.78

u/ml

1.30

2660

13166

Other disorders of patella

2534

18391

1.53

65.22

1.4

1.3

1.29

1.92

u/ml

2.28

677

5360

Anorexia (incl.atypical)

1153

7284

1.99

65.04

1.7

1.4

1.03

1.66

u/ml

2.40

327

2051

Other metabolic disorders

2091

14758

1.61

65.02

1.4

1.3

1.48

1.53

u/ml

0.07

604

4170

Alcohol use disorder, Swedish definition

7109

53182

1.28

64.96

1.4

1.3

2.00

1.80

u/ml

0.46

1815

15061

Congenital malformations, deformations and chromosomal abnormalities

9581

77231

1.24

64.84

1.4

1.60

1.63

u/ml

0.10

2629

22054

Emotional disorders starting during childhood or adolecense, excluding more controls

1001

5961

2.14

64.71

1.8

1.5

1.81

2.00

u/ml

0.18

233

1627

Small fibre neuropathy

478

2268

2.89

64.68

1.6

1.3

0.98

1.53

u/ml

1.06

110

619

All influenza

3598

27478

1.42

64.38

1.4

1.3

1.70

1.75

u/ml

0.07

941

7357

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

9508

62726

1.25

64.32

1.4

1.3

1.38

1.51

u/ml

0.58

2925

17821

Lactose intolerance

578

2986

2.66

63.99

1.6

1.4

1.14

1.83

u/ml

1.10

128

815

6-mercaptopurine

681

3725

2.46

63.92

1.5

1.4

1.00

1.83

u/ml

1.21

185

1033

Heart failure and antihypertensive medication

2832

13355

1.48

63.84

1.4

1.3

1.89

1.96

u/ml

0.07

719

3600

Superficial injury of lower leg

4096

32010

1.39

63.83

1.4

1.74

1.68

u/ml

0.09

1049

8913

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

6610

53867

1.30

63.82

1.4

1.77

1.64

u/ml

0.29

1745

15699

Adrenocortical insufficiency

618

3260

2.54

63.81

1.7

1.3

1.23

1.47

u/ml

0.33

227

885

Hernia of abdominal wall

5837

47303

1.31

63.72

1.3

1.62

1.76

u/ml

0.34

1533

12916

Other and unspecified mood [affective] disorders

1310

8511

1.86

63.61

1.5

1.3

1.02

1.49

u/ml

1.38

298

2549

Enlarged lymph nodes

2192

15538

1.56

63.36

1.4

1.3

1.56

1.94

u/ml

0.79

651

4246

Non-rheumatic valve diseases

5731

32890

1.31

62.74

1.3

1.94

1.84

u/ml

0.17

1527

8463

Other/unspecified synovitis and tenosynovitis

1585

10599

1.69

62.54

1.4

1.3

1.63

1.87

u/ml

0.33

436

2903

Covid-19 suspected case

3476

26742

1.43

62.46

1.4

1.50

1.69

u/ml

0.41

1066

7637

Fracture of forearm

8538

64698

1.25

62.32

1.4

1.3

1.85

1.58

u/ml

0.93

2143

17600

Lichen planus, including avohilmo

2575

18912

1.51

61.85

1.4

1.3

1.70

1.75

u/ml

0.07

696

5014

Diabetes mellitus in pregnancy

6087

31757

1.33

61.78

1.5

1.3

1.54

1.48

u/ml

0.16

2012

9529

Disorders of ocular muscles, binocular movement, accommodation and refraction

7729

64291

1.27

61.71

1.4

1.62

1.67

u/ml

0.13

2200

17887

Infective dermatitis

1527

10183

1.71

61.42

1.4

1.3

1.42

2.00

u/ml

1.80

490

2725

Cutaneous abscess, furuncle and carbuncle

3808

29594

1.40

61.24

1.5

1.3

1.96

1.77

u/ml

0.32

998

8353

Valvular heart disease excluding rheumatic fever

5764

33243

1.30

60.81

1.3

1.93

1.85

u/ml

0.14

1533

8532

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2648

19708

1.51

60.74

1.5

1.4

1.53

1.75

u/ml

0.34

655

5784

Infections with a predominantly sexual mode of transmission

5184

41962

1.34

60.71

1.4

1.3

1.89

1.48

u/ml

1.03

1253

12544

Other hammer toe(s) (acquired)

2116

13604

1.56

60.64

1.3

1.51

2.01

u/ml

1.09

467

3420

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1935

13646

1.62

60.60

1.4

1.3

1.51

1.50

u/ml

0.02

562

3894

Psoriasis vulgaris

2481

18145

1.51

60.47

1.4

1.3

1.98

1.82

u/ml

0.20

691

5039

Sequelae of external causes of morbidity and mortality

3390

25947

1.42

60.34

1.4

1.3

1.70

1.74

u/ml

0.06

935

6971

Dermatographic urticaria

1165

7478

1.91

60.32

1.5

1.3

1.14

1.48

u/ml

0.73

369

2148

Barrett oesophagus

628

3307

2.30

60.20

1.4

1.3

1.82

1.94

u/ml

0.08

108

891

Benign thyroid growths and nodules

4405

32383

1.36

60.01

1.3

1.06

1.59

u/ml

5.17

1179

8423

Other diseases of pancreas

1072

6621

1.88

60.00

1.4

1.3

2.10

1.72

u/ml

0.27

275

1703

Gonarthrosis,primary

11422

59185

1.21

59.97

1.3

1.65

1.72

u/ml

0.23

3078

15924

Biguanides

13907

73310

1.19

59.60

1.3

1.56

1.67

u/ml

0.43

3860

20427

Glomerular disorders in diseases classified elsewhere

1449

9611

1.71

59.36

1.6

1.3

2.33

2.02

u/ml

0.30

407

2565

Disorders of muscles

1404

9253

1.72

59.19

1.4

1.3

2.29

1.95

u/ml

0.29

378

2529

Coronary atherosclerosis

7656

40162

1.26

59.16

1.4

1.3

1.65

1.82

u/ml

0.49

2043

10079

Superficial injury of wrist and hand

3402

26276

1.42

59.14

1.4

1.79

1.72

u/ml

0.11

881

7400

Crohn disease (strict definition, all UC cases excluded)

861

5140

2.11

59.05

1.4

0.80

1.68

u/ml

3.09

233

1464

Other diseases of oesophagus

1123

6994

1.82

58.91

1.4

1.3

1.47

1.83

u/ml

0.39

286

1831

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1125

7181

1.90

58.85

1.4

0.86

1.61

u/ml

3.21

296

2050

Ocular pain

1403

9402

1.77

58.80

1.5

1.3

1.25

1.50

u/ml

0.52

359

2654

Plantar fascial fibromatosis

1404

9308

1.73

58.51

1.4

1.3

1.64

1.88

u/ml

0.28

354

2549

7672

57404

1.25

58.16

1.4

1.3

1.97

1.76

u/ml

0.52

1958

16203

Ascites

912

5414

1.94

58.10

1.3

3.59

1.83

u/ml

1.29

216

1429

Sulfasalazine

3946

30953

1.37

58.07

1.3

1.10

1.79

u/ml

6.22

1059

8698

Cerebrovascular diseases (FINNGEN)

4145

22722

1.36

58.07

1.4

1.3

1.27

1.71

u/ml

2.12

1109

6429

Arthropathies in other diseases classified elsewhere

533

2719

2.49

57.85

1.7

1.3

1.48

1.89

u/ml

0.37

154

714

Diabetic neuropathy

1418

9418

1.72

57.84

1.6

1.4

1.63

1.62

u/ml

0.02

406

2606

Crohn disease (strict definition, require KELA)

1063

6726

1.93

57.82

1.4

0.88

1.62

u/ml

2.98

284

1922

Other symptoms and signs involving the circulatory and respiratory systems

946

5714

1.94

57.82

1.4

1.3

1.84

1.89

u/ml

0.03

273

1526

Cellulitis

3053

23199

1.43

57.53

1.5

1.3

2.28

1.83

u/ml

0.65

774

6351

Acute pancreatitis

2312

16754

1.50

57.51

1.4

1.3

2.13

1.89

u/ml

0.29

619

4509

Keratitis

5115

41440

1.32

57.45

1.4

1.3

1.82

1.67

u/ml

0.32

1499

11499

Other symptoms and signs involving the urinary system

1308

8536

1.73

57.31

1.4

1.3

1.61

2.00

u/ml

0.55

511

2254

Mental and behavioural disorders due to psychoactive substance use

8237

63753

1.24

57.28

1.4

1.3

1.79

1.74

u/ml

0.12

2071

18089

Crohn disease (strict definition, require KELA, min 2 HDR)

1048

6634

1.93

56.94

1.4

0.86

1.60

u/ml

2.96

280

1895

Carbimazole or st.post thyroidectomy, condition for graves disease

3112

23878

1.44

56.92

1.4

1.3

1.80

1.58

u/ml

0.45

810

6702

Spondylopathies (FG)

1974

14060

1.57

56.91

1.3

1.11

1.90

u/ml

3.18

562

4027

Autoimmune hyperthyroidism

961

5911

1.95

56.74

1.5

1.3

1.81

1.23

u/ml

0.89

254

1629

Adjustment and management of implanted device

1974

13910

1.54

56.72

1.4

1.3

2.03

1.91

u/ml

0.10

381

3481

Otalgia

1349

9028

1.77

56.68

1.5

1.4

1.35

1.66

u/ml

0.36

321

2361

Other follicular disorders

1205

7860

1.82

56.56

1.5

1.3

1.34

1.71

u/ml

0.61

400

2229

Spondyloarthritis

2361

17280

1.49

56.15

1.3

1.19

1.85

u/ml

2.41

662

4913

Disorders of breast

8135

60915

1.25

56.08

1.4

1.3

1.17

1.47

u/ml

1.91

2237

17118

Dislocation, sprain and strain of joints and ligaments at neck level

2481

18523

1.50

55.66

1.4

1.39

1.70

u/ml

0.61

711

5365

Substance abuse

7929

62204

1.24

55.65

1.4

1.3

1.82

1.75

u/ml

0.14

1973

17668

Other disorders of adrenal gland

756

4440

2.17

55.30

1.7

1.4

1.20

1.70

u/ml

1.00

260

1191

8099

59585

1.24

55.02

1.4

1.3

1.93

1.75

u/ml

0.44

2078

16886

Glomerular diseases

2211

16099

1.51

54.74

1.5

1.3

1.94

1.96

u/ml

0.02

638

4295

Ventral hernia

2953

22429

1.42

54.67

1.3

1.43

1.77

u/ml

0.73

762

6081

Transient ischemic attack

6054

39645

1.27

54.52

1.3

1.32

1.76

u/ml

2.65

1546

10115

Fracture of foot, except ankle

3780

29858

1.37

54.32

1.4

1.3

2.02

1.64

u/ml

0.73

945

8525

Striking against or struck by other objects

5023

40853

1.31

54.07

1.4

2.16

1.72

u/ml

1.09

1178

11523

Intestinal adhesions without obstruction

987

6088

1.83

53.72

1.4

1.3

2.03

1.84

u/ml

0.13

217

1637

Neuromuscular dysfunction of bladder

1165

7541

1.76

53.40

1.4

1.3

1.30

1.80

u/ml

0.98

247

2030

Bulimia nervosa (incl. atypical)

732

4394

2.28

53.25

1.6

1.4

0.84

1.80

u/ml

3.34

199

1286

Psoriatic and enteropathic arthropathies

1593

11051

1.62

52.76

1.4

1.3

1.27

1.91

u/ml

1.30

460

3101

Fracture of femur

3006

20574

1.40

52.75

1.3

1.80

u/ml

0.01

751

5033

Viral warts, including avohilmo

3453

27127

1.39

52.69

1.5

1.4

1.52

1.74

u/ml

0.53

1007

7612

Other noninflammatory disorders of vagina

1193

7849

1.77

52.65

1.4

1.3

1.34

1.91

u/ml

1.18

320

2175

Suppurative and unspecified otitis media

6163

45578

1.28

52.27

1.5

1.4

1.95

1.61

u/ml

0.97

1644

13170

Malignant neoplasm of respiratory system and intrathoracic organs

1127

14393

0.61

52.15

1.2

1.3

2.13

1.80

u/ml

0.36

235

3674

Superficial injury of head

3364

26189

1.38

52.09

1.3

1.66

1.77

u/ml

0.17

795

7052

Otitis externa

3279

25570

1.39

51.95

1.4

1.38

1.80

u/ml

1.41

773

7088

Fracture of lower leg, including ankle

7903

66006

1.23

51.93

1.4

1.3

2.02

1.64

u/ml

1.25

2055

18180

Intestinal stricture

3647

28641

1.36

51.88

1.3

1.88

1.73

u/ml

0.22

952

7438

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1342

16364

0.63

51.64

1.2

1.3

2.14

1.78

u/ml

0.46

285

4175

Other disorders of penis

1073

6798

1.76

51.59

1.4

1.3

1.83

2.32

u/ml

0.56

254

1824

Other problems related to primary support group, including family circumstances

2046

14707

1.57

51.51

1.7

1.5

1.60

1.80

u/ml

0.38

550

4110

Other bullous disorders

444

2244

2.67

51.50

2.0

1.3

6.65

1.84

u/ml

3.47

162

614

Other/unspecified enthesopathies of lower limb, excluding foot

1070

6889

1.81

51.50

1.4

1.3

0.76

1.92

u/ml

7.95

288

1885

Other noninflammatory disorders of uterus, except cervix

2730

13714

1.44

51.43

1.3

1.40

1.85

u/ml

1.09

707

3603

Psoriatic arthropathies

1332

8952

1.68

51.37

1.3

1.36

2.19

u/ml

1.47

393

2493

Atrophic disorders of skin

2351

17593

1.49

51.37

1.4

1.3

1.71

1.62

u/ml

0.13

677

4813

Disorders of continuity of bone

1496

10370

1.65

51.34

1.5

1.3

1.90

1.75

u/ml

0.13

402

2828

Sequelae with surgical and medical care as external cause

2603

19661

1.44

51.28

1.4

1.3

1.74

1.76

u/ml

0.01

718

5247

Lesion of ulnar nerve

1770

12554

1.56

51.20

1.3

1.74

1.94

u/ml

0.23

508

3501

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

966

6044

1.84

51.04

1.4

1.3

2.31

1.58

u/ml

0.65

256

1540

Angina pectoris

6436

35456

1.26

50.94

1.3

1.35

1.86

u/ml

3.08

1809

8642

Nonsuppurative otitis media, including avohilmo

5481

39254

1.30

50.86

1.5

1.4

1.84

1.67

u/ml

0.32

1422

11154

Unspecified haematuria

4768

31346

1.30

50.78

1.3

1.39

1.84

u/ml

2.25

1155

8224

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

605

3335

2.18

50.78

1.3

1.00

1.63

u/ml

1.89

136

842

Lichen planus

1702

12064

1.58

50.68

1.4

1.3

1.47

1.60

u/ml

0.21

465

3168

Localized swelling, mass and lump of skin and subcutaneous tissue

4359

35174

1.32

50.64

1.4

1.3

1.45

1.76

u/ml

0.95

1092

9680

Fracture of shoulder and upper arm

4897

39939

1.30

50.26

1.4

1.3

2.11

1.73

u/ml

0.74

1181

10505

Benign neoplasm: Descending colon

867

5316

1.90

50.22

1.3

2.68

1.41

u/ml

0.73

227

1386

Redundant prepuce, phimosis and paraphimosis

2278

16494

1.45

50.13

1.4

1.3

1.77

2.07

u/ml

0.52

643

4690

Anogenital herpesviral [herpes simplex] infection, including avohilmo

2022

14971

1.55

50.03

1.4

1.36

1.55

u/ml

0.30

544

4554

Endometriosis ASRM stages 1,2

2904

22609

1.44

49.99

1.4

1.3

1.23

1.48

u/ml

0.87

864

6627

Rheumatoid arthritis, including avohilmo

4959

40651

1.30

49.55

1.3

1.09

1.67

u/ml

5.70

1323

10929

Other specified and unspecified personality disorders

1379

9505

1.68

49.52

1.5

1.3

1.15

1.58

u/ml

1.04

357

2783

Malignant neoplasm of bronchus and lung, including Hilmo

1131

14351

0.62

49.50

1.2

1.3

2.18

1.73

u/ml

0.56

237

3636

Malignant neoplasm of bronchus and lung

943

12483

0.59

49.46

1.2

1.3

2.13

1.72

u/ml

0.41

195

3180

L04AD Calcineurin inhibitors

1529

10731

1.63

49.34

1.5

1.4

1.29

2.01

u/ml

1.64

390

2860

Rosacea

1923

14046

1.54

49.30

1.4

1.3

1.38

1.58

u/ml

0.29

556

3951

Speech and linguistic disorders, excluding more controls

1424

9263

1.67

49.22

1.6

1.5

2.30

1.80

u/ml

0.47

327

2591

Hyperparathyroidism

2209

16155

1.47

49.14

1.3

1.39

1.62

u/ml

0.40

539

4099

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1830

13169

1.53

48.94

1.4

1.3

1.77

1.88

u/ml

0.11

394

3497

Vulvovaginal ulceration/inflammation in other diseases

1260

8652

1.76

48.80

1.4

1.79

1.65

u/ml

0.11

363

2552

Disorders of calcium metabolism

880

5470

1.88

48.77

1.4

1.3

0.99

1.60

u/ml

1.41

246

1455

Autoimmune hepatitis

200

744

4.81

48.54

1.6

1.3

1.14

0.86

u/ml

0.47

207

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

4520

36885

1.31

48.54

1.4

1.49

1.71

u/ml

0.64

1213

10526

Schizophrenia or delusion, excluding more controls

4114

32671

1.32

48.46

1.4

1.3

1.98

1.73

u/ml

0.40

1049

9724

Tongue abnormality

857

5339

1.92

48.44

1.5

1.3

1.20

1.42

u/ml

0.33

239

1404

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1569

21497

0.66

48.36

1.2

1.3

1.18

1.75

u/ml

2.07

421

5686

Acute gastritis

896

5560

1.84

48.35

1.4

1.3

2.51

1.74

u/ml

0.50

260

1510

3069

20304

1.37

48.27

1.3

1.99

1.76

u/ml

0.34

753

4697

Charcot foot

289

1252

3.22

48.18

1.8

1.2

1.44

1.85

u/ml

0.31

328

Suicide or other Intentional self-harm

3613

28816

1.36

48.06

1.4

1.3

1.54

1.67

u/ml

0.23

873

8373

Other and unspecified rosacea

1333

9171

1.68

47.93

1.4

1.3

1.56

1.71

u/ml

0.15

380

2554

Other disorders of bone

2777

21441

1.41

47.56

1.4

1.3

1.76

1.72

u/ml

0.05

741

6036

Raynaud syndrome

1373

9565

1.67

47.21

1.4

1.3

1.33

1.54

u/ml

0.22

375

2703

Appendectomy

9830

81585

1.20

47.20

1.4

1.3

1.55

1.60

u/ml

0.16

2836

23171

Unspecified mental disorder

5843

48932

1.26

47.17

1.4

1.3

1.64

1.67

u/ml

0.05

1511

14150

Adalimumab

1558

11097

1.61

47.13

1.4

1.27

1.76

u/ml

0.99

455

3173

Early onset COPD, excluding more controls

2210

16357

1.44

46.95

1.3

1.68

2.02

u/ml

0.56

526

4564

Oxycodone

4560

31617

1.29

46.89

1.3

1.46

1.81

u/ml

1.32

1191

8440

Other protozoal intestinal diseases

290

1309

3.42

46.74

1.6

1.3

2.06

1.78

u/ml

0.08

341

Retention of urine

3610

23024

1.33

46.56

1.3

1.59

1.84

u/ml

0.71

929

5974

Abnormal findings on diagnostic imaging of other body structures

1931

14182

1.51

46.52

1.4

1.3

1.68

1.72

u/ml

0.05

506

3841

L04AC Interleukin inhibitors

1015

6665

1.81

46.47

1.4

1.3

1.01

1.70

u/ml

1.38

296

1895

Lactose intolerance, other/unspecified

482

2606

2.45

46.43

1.6

1.4

1.23

1.75

u/ml

0.61

106

700

Acute appendicitis, no complications

8232

70575

1.21

46.23

1.4

1.3

1.60

1.64

u/ml

0.11

2393

20316

Acute tubulo-interstitial nephritis

9038

66067

1.20

46.22

1.4

1.3

1.42

1.65

u/ml

1.29

2362

17879

Cholangitis (primary sclerosing, PSC)

805

4941

1.89

46.21

1.5

1.3

1.90

2.07

u/ml

0.12

191

1270

Diseases of appendix

10978

86230

1.18

46.13

1.3

1.65

1.63

u/ml

0.06

3137

24398

Gluteal tendinitis

664

3917

2.07

46.10

1.4

1.3

2.02

1.94

u/ml

0.04

160

1008

Nummular dermatitis

1053

6894

1.74

46.04

1.4

1.3

1.60

1.88

u/ml

0.31

302

1814

Polymyalgia rheumatica

1463

10178

1.58

46.01

1.3

1.41

1.69

u/ml

0.42

356

2525

Hypopituitarism

1046

6900

1.77

45.79

1.5

1.4

1.05

2.00

u/ml

3.49

321

1815

Presbycusis

1368

9204

1.58

45.76

1.3

1.2

1.51

1.54

u/ml

0.03

312

2104

Sequelae of injuries, of poisoning and of other consequences of external causes

3126

24581

1.37

45.59

1.4

1.3

2.16

1.72

u/ml

0.62

734

6961

Glaucoma

6715

48202

1.23

45.54

1.3

1.52

1.70

u/ml

0.53

1877

12153

Graves disease, strict definition

1597

11513

1.59

45.51

1.4

1.3

2.02

1.59

u/ml

0.56

447

3325

Dissociative [conversion] disorders

705

4306

2.08

45.46

1.5

1.3

2.01

1.52

u/ml

0.32

214

1266

Substance use, excluding alcohol

2827

22004

1.40

45.37

1.4

1.3

2.32

1.77

u/ml

0.74

636

6389

Hypermobility syndrome

985

6554

1.87

45.35

1.5

1.4

0.83

1.44

u/ml

1.13

307

1929

Appendicitis, broad definition

10883

85902

1.18

44.87

1.4

1.3

1.64

1.62

u/ml

0.04

3114

24317

Explicit Sepsis, including avohilmo

5705

43194

1.25

44.81

1.4

1.3

1.68

1.76

u/ml

0.20

1512

11399

Atypical facial pain

778

4849

1.94

44.40

1.5

1.3

1.44

u/ml

0.00

198

1313

Mental and behavioural disorders due to alcohol, excluding acute intoxication

5434

44898

1.26

44.20

1.4

1.3

1.83

1.82

u/ml

0.02

1419

12696

Gout, FINNGEN

2830

21715

1.36

44.13

1.3

1.98

1.86

u/ml

0.15

670

5473

Diplopia

1697

12295

1.53

44.12

1.4

1.3

1.86

1.90

u/ml

0.03

448

3326

Gout, idiopatic and unspecified

2455

18636

1.40

44.10

1.3

2.16

1.84

u/ml

0.41

573

4759

Other and unspecified visual disturbances

1496

10658

1.58

44.00

1.4

1.3

2.94

1.64

u/ml

1.34

347

2857

Open wound of head

7258

58250

1.22

43.94

1.4

1.3

1.95

1.81

u/ml

0.35

1753

15828

Agoraphobia

611

3626

2.17

43.92

1.5

1.3

1.40

1.31

u/ml

0.09

124

1105

Supplementary factors related to causes of morbidity and mortality classified elsewhere

4418

36282

1.30

43.91

1.4

1.3

1.75

1.69

u/ml

0.11

1516

9905

Other bacterial diseases, including avohilmo

15229

85151

1.15

43.86

1.4

1.3

1.71

1.67

u/ml

0.15

4013

23725

Acute pancreatitis (for exclusion)

2312

17501

1.42

43.73

1.4

1.3

2.13

1.93

u/ml

0.23

619

4718

Explicit Sepsis

5552

42228

1.25

43.70

1.4

1.3

1.69

1.77

u/ml

0.17

1463

11146

Drug-induced osteoporosis with pathological fracture

288

1325

3.21

43.69

1.5

1.3

0.85

1.42

u/ml

1.05

331

Mental and behavioural disorders due to alcohol

6567

53059

1.23

43.63

1.4

1.3

1.72

1.81

u/ml

0.19

1710

15067

Alcohol abuse, main dg, excluding more controls

1873

13756

1.48

43.60

1.4

1.3

1.56

1.84

u/ml

0.40

455

4075

Vitamin deficiency, wide

709

4318

1.97

43.53

1.5

1.3

2.25

1.53

u/ml

0.43

204

1171

Vitamin deficiency

709

4318

1.97

43.53

1.5

1.3

2.25

1.53

u/ml

0.43

204

1171

Acute pharyngitis

2508

19211

1.42

43.20

1.5

1.4

1.84

1.86

u/ml

0.03

709

5371

Type of accident

4090

33394

1.31

43.05

1.4

1.3

1.77

1.72

u/ml

0.07

1413

9122

Unspecified urinary incontinence

1223

8429

1.65

42.97

1.4

1.3

2.01

1.50

u/ml

0.38

162

2160

False labour

5379

28048

1.29

42.93

1.4

1.19

1.54

u/ml

1.78

1746

8330

Superficial injury of abdomen, lower back and pelvis

2269

17303

1.43

42.59

1.4

1.3

1.59

1.75

u/ml

0.26

610

4813

Coagulation defects, purpura and other haemorrhagic conditions

2595

20127

1.40

42.58

1.4

1.3

2.01

1.79

u/ml

0.32

688

5486

Seborrhoeic dermatitis

1258

8679

1.62

42.58

1.5

1.3

1.35

1.80

u/ml

1.08

359

2294

Secondary hypertension

990

6377

1.72

42.58

1.4

1.3

2.11

2.17

u/ml

0.04

266

1641

Lichen sclerosus et atrophicus

1633

11905

1.54

42.35

1.4

1.3

1.71

1.61

u/ml

0.11

486

3166

Influenza and pneumonia

16563

92188

1.14

42.22

1.4

1.3

1.79

1.65

u/ml

0.54

4336

25851

Other skin changes

2498

19267

1.40

42.10

1.3

1.19

1.75

u/ml

3.11

642

5146

Flat foot [pes planus] (acquired)

1320

9246

1.60

41.91

1.4

1.3

1.63

1.97

u/ml

0.36

367

2487

Seropositive rheumatoid arthritis

3055

24013

1.35

41.73

1.3

1.11

1.79

u/ml

4.42

806

6300

2204

15471

1.41

41.68

1.3

1.91

1.77

u/ml

0.16

543

3562

SLE (Finngen)

522

2968

2.19

41.49

1.5

1.3

1.29

u/ml

0.00

126

786

Primary Sclerosing Cholangitis, IBD and UDCA required

375

1936

2.62

41.48

1.6

1.4

1.29

1.89

u/ml

0.86

503

Female infertility, associated with anovulation

1409

10109

1.60

41.45

1.4

1.3

1.19

1.60

u/ml

0.94

566

3099

Other and unspecified tonsillitis

5490

38420

1.26

41.43

1.4

1.60

1.72

u/ml

0.30

1618

11199

Hypoparathyroidism

544

3155

2.17

41.16

1.5

1.3

0.81

1.53

u/ml

2.14

175

794

Gout, strict definition

1758

12828

1.47

41.14

1.3

1.91

1.94

u/ml

0.03

411

3234

Neuralgia and neuritis, unspecified

715

4407

1.91

41.12

1.4

1.3

0.75

1.59

u/ml

4.38

171

1166

Superficial injury of hip and thigh

1897

14085

1.46

41.03

1.4

1.3

1.98

1.77

u/ml

0.26

473

3713

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

3520

28647

1.34

40.83

1.5

1.4

1.50

1.54

u/ml

0.08

951

8611

Endometriosis of rectovaginal septum and vagina

1070

7259

1.69

40.81

1.4

1.3

1.05

1.93

u/ml

3.21

323

1965

Alcohol use disorder, ICD-based

5024

41912

1.26

40.80

1.3

1.86

1.80

u/ml

0.10

1313

11845

Chronic periodontitis, complicated

7151

59929

1.21

40.78

1.3

1.55

1.68

u/ml

0.43

1637

16417

Ulcerative proctitis

920

6071

1.78

40.73

1.4

1.3

1.01

1.67

u/ml

1.62

219

1743

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

833

5395

1.84

40.63

1.4

1.3

1.66

1.58

u/ml

0.08

222

1400

Cluster headache, wide

598

3552

2.05

40.61

1.5

1.3

1.03

1.80

u/ml

1.80

165

1018

Erysipelas, including avohilmo

9778

63500

1.18

40.57

1.3

1.72

1.69

u/ml

0.09

2661

17416

Acute appendicitis

10180

83340

1.18

40.49

1.3

1.67

1.63

u/ml

0.11

2916

23662

Disorders of refraction and accommodation

4440

36749

1.29

40.41

1.4

1.94

1.79

u/ml

0.26

1241

10240

Gout, unspecified

1996

14898

1.43

40.39

1.3

2.15

1.91

u/ml

0.25

454

3773

Emotional disorders and disorders of social functioning with onset specific to childhood

1095

7520

1.78

40.33

1.8

1.6

1.70

1.89

u/ml

0.19

249

1932

Dermatitis herpetiformis

297

1424

2.94

40.22

2.2

1.3

8.49

1.48

u/ml

4.14

120

374

Bacterial infection, other or unspecified, including avohilmo

7550

53336

1.20

40.13

1.4

1.3

1.70

1.75

u/ml

0.11

1770

14134

Hypertrophy of breast in women and men

2928

23340

1.37

40.10

1.4

1.3

1.12

1.59

u/ml

2.26

924

6746

Other bursopathies

1520

10926

1.52

40.01

1.3

1.51

2.06

u/ml

1.04

389

2893

Erysipelas

6909

51035

1.21

39.64

1.3

1.75

1.73

u/ml

0.04

1818

13714

Problems related to lifestyle

1484

10734

1.53

39.17

1.4

1.3

1.48

1.79

u/ml

0.35

413

3034

Other abnormal immunological findings in serum

388

2098

2.60

39.12

1.9

1.4

5.23

2.01

u/ml

2.51

125

560

Oesophagitis

650

3934

1.91

39.06

1.4

1.3

1.70

1.98

u/ml

0.32

157

1073

Cluster headache, strict

565

3345

2.07

39.06

1.5

1.3

1.05

1.85

u/ml

1.73

153

966

Other disorders starting during childhood or adolecense, excluding more controls

926

5956

1.80

39.04

1.7

1.5

2.06

2.08

u/ml

0.01

230

1594

Other female pelvic inflammatory diseases

2306

17931

1.42

39.01

1.4

1.3

1.21

1.55

u/ml

0.81

575

5010

Certain disorders involving the immune mechanism

2403

18670

1.39

38.97

1.4

1.3

2.21

1.79

u/ml

0.55

625

5158

Disorders of psychological development

2173

15601

1.45

38.89

1.6

1.5

2.00

1.92

u/ml

0.08

505

4171

Volume depletion

1066

7201

1.62

38.55

1.4

1.3

1.20

1.89

u/ml

1.31

326

1819

Acne

2027

15537

1.47

38.42

1.6

1.4

1.84

1.72

u/ml

0.16

632

4355

Complications of internal orthopaedic prosthetic devices, implants and grafts

2557

19974

1.37

38.28

1.4

1.3

1.50

1.89

u/ml

0.84

612

5126

Hallux rigidus

1597

11678

1.49

38.17

1.3

1.02

2.19

u/ml

4.53

372

3049

D07AA Corticosteroids, weak (group I)

2392

18691

1.40

38.17

1.4

2.13

1.80

u/ml

0.44

661

5177

Palmar fascial fibromatosis [Dupuytren]

1388

9823

1.51

38.14

1.4

1.2

2.11

2.16

u/ml

0.03

308

2445

Ankylosing spondylitis

1087

7441

1.63

38.13

1.3

1.11

1.89

u/ml

2.24

289

2061

Abnormal findings in secretions and smears from cervix uteri vagina vulva

8391

54174

1.20

38.08

1.4

1.3

1.30

1.43

u/ml

0.53

2536

15713

Primary hyperparathyroidism

1401

10111

1.55

38.05

1.3

1.11

1.51

u/ml

1.07

359

2627

Pacemaker

3665

27632

1.29

37.99

1.3

1.77

1.78

u/ml

0.01

989

6669

Hyperhidrosis

555

3314

2.09

37.96

1.5

1.3

1.11

1.54

u/ml

0.66

151

925

Umbilical hernia

3235

26028

1.32

37.91

1.3

1.83

1.82

u/ml

0.01

875

7324

Anomalies of dental arch relationship, including avohilmo

3287

24172

1.34

37.79

1.5

1.4

1.58

1.80

u/ml

0.49

907

6746

Other complications of surgical and medical care, not elsewhere classified

1369

9859

1.56

37.78

1.4

1.3

1.78

1.74

u/ml

0.03

356

2715

Impotence

572

3348

1.93

37.69

1.5

1.3

2.71

2.62

u/ml

0.04

148

922

Other specified/unspecified bacterial intestinal infections

866

5707

1.75

37.66

1.4

1.3

2.02

1.44

u/ml

0.42

193

1526

Nail disorders

1189

8377

1.61

37.40

1.5

1.3

1.13

1.83

u/ml

2.97

335

2252

Contact with and exposure to communicable diseases

5230

44289

1.25

37.39

1.4

1.21

1.63

u/ml

2.48

2323

12413

Varicose veins

7605

49776

1.20

37.31

1.3

1.41

1.64

u/ml

1.07

2176

13260

Habitual aborter

405

2239

2.43

37.30

1.4

1.3

1.58

1.97

u/ml

0.25

115

668

Scoliosis

1329

9584

1.57

37.21

1.5

1.4

1.37

1.82

u/ml

0.75

349

2525

Other/unspecified enthesopathies, not elsewhere classified

1011

6843

1.64

37.21

1.4

1.3

1.01

1.93

u/ml

4.20

284

1833

Other septicaemia, including avohilmo

4604

36004

1.25

37.20

1.4

1.3

1.64

1.80

u/ml

0.39

1187

9251

Other specified/unspecified systemic involvement of connective tissue

821

5410

1.79

36.97

1.5

1.3

1.88

1.53

u/ml

0.32

217

1490

Postprocedural disorders of nervous system

1164

8259

1.64

36.95

1.5

1.4

1.36

1.49

u/ml

0.16

363

2403

Superficial injury of thorax

1934

14666

1.43

36.94

1.4

1.3

1.75

1.85

u/ml

0.10

502

4009

Glucosamine medication

5221

35112

1.24

36.91

1.3

1.28

1.69

u/ml

1.71

1228

8628

Oligomenorrhoea

608

3761

2.00

36.72

1.4

1.64

2.11

u/ml

0.29

172

1075

Other septicaemia

4484

35202

1.26

36.53

1.4

1.3

1.66

1.80

u/ml

0.33

1145

9059

Disorder of lipoprotein metabolism, unspecified

1373

9833

1.51

36.47

1.3

2.28

1.78

u/ml

0.46

336

2528

Other viral diseases

4460

37280

1.27

36.46

1.4

1.47

1.76

u/ml

0.80

1268

10407

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1252

8941

1.58

36.37

1.5

1.3

1.91

1.56

u/ml

0.27

316

2446

Bacterial infection, other or unspecified

6662

48366

1.21

36.37

1.4

1.3

1.61

1.72

u/ml

0.29

1490

12702

Other specified/unspecified inflammatory spondylopathies

707

4504

1.85

36.34

1.4

1.3

1.31

1.67

u/ml

0.35

225

1321

Other disorders of the musculoskeletal system and connective tissue

1804

13595

1.45

36.31

1.4

1.3

1.48

1.84

u/ml

0.48

446

3682

Enterocolitis due to Clostridium difficile

1238

8741

1.55

36.30

1.4

1.3

1.39

1.50

u/ml

0.12

278

2278

Fracture at wrist and hand level

4862

40855

1.25

36.28

1.4

1.3

1.83

1.76

u/ml

0.11

1226

11531

Wide developmental disorders, excluding more controls

637

3926

1.98

36.14

1.6

1.5

1.61

2.10

u/ml

0.41

152

1014

Nonalcoholic steatohepatitis

191

811

3.94

36.10

1.5

1.3

0.93

1.82

u/ml

0.93

235

Oral lichen planus, including avohilmo , including avohilmo

974

6683

1.68

35.80

1.4

1.3

1.65

1.56

u/ml

0.08

283

1811

Acute suppurative otitis media

4545

35703

1.27

35.80

1.5

1.4

2.11

1.64

u/ml

1.14

1250

10346

Childhood allergy (age < 16)

2989

20065

1.36

35.80

1.6

1.5

1.98

1.76

u/ml

0.39

781

5532

Other superficial mycoses, including avohilmo

1674

12597

1.48

35.79

1.4

1.71

1.64

u/ml

0.08

430

3634

Presence of cardiac and vascular implants and grafts

4458

27186

1.25

35.78

1.3

1.91

1.95

u/ml

0.07

1008

6738

Other Crohn's disease

1015

7023

1.66

35.64

1.4

1.3

0.73

1.70

u/ml

7.00

249

2007

ILD, hospital admission 2, with pulmonary infections

1048

7184

1.60

35.45

1.4

1.3

1.27

2.06

u/ml

2.24

273

1807

Reactive arthropathies

1112

7768

1.60

35.43

1.4

1.3

1.79

2.21

u/ml

0.50

298

2131

Other bacterial diseases

13317

79365

1.14

35.43

1.4

1.3

1.70

1.71

u/ml

0.02

3330

22022

Other and unspecified follicular disorders

607

3761

1.94

35.32

1.4

1.3

1.01

1.61

u/ml

1.11

213

1062

Combinations of oral blood glucose lowering drugs

3003

24120

1.31

35.31

1.3

1.62

1.91

u/ml

0.57

856

6326

Dermatophytosis

1665

12439

1.46

35.31

1.4

1.3

1.94

1.93

u/ml

0.01

482

3314

Other disorders of kidney and ureter

1503

11052

1.49

35.24

1.3

1.72

2.01

u/ml

0.30

350

2887

Excessive vomiting in pregnancy

1360

10014

1.57

35.21

1.5

1.3

1.62

1.58

u/ml

0.04

413

2919

Haemorrhage in early pregnancy

4409

36105

1.27

35.21

1.3

1.20

1.41

u/ml

0.73

1301

10383

Diseases of arteries, arterioles and capillaries

7701

49137

1.19

35.20

1.4

1.3

1.60

1.74

u/ml

0.44

1923

12795

Primary adrenocortical insufficiency

218

991

3.48

35.19

2.1

1.3

1.41

1.77

u/ml

0.20

272

Iridocyclitis

2911

23417

1.33

35.13

1.4

1.3

1.50

1.73

u/ml

0.56

858

6406

Any event in hilmo or specialist outpatient

101

6.12

34.97

1.4

1.1

1.29

2.48

u/ml

0.26

Kela-code for severe mental illness

4992

42352

1.24

34.82

1.4

1.3

1.68

1.67

u/ml

0.02

1322

12187

Glaucoma suspect

4282

35752

1.26

34.77

1.4

1.3

1.59

1.69

u/ml

0.20

1267

9078

Coxarthrosis, primary

6852

49207

1.20

34.70

1.3

1.52

1.74

u/ml

0.73

1714

12603

Herpesviral [herpes simplex] infections

1641

12336

1.47

34.69

1.4

1.3

1.75

1.70

u/ml

0.05

461

3452

Seronegative rheumatoid arthritis

1422

10402

1.50

34.55

1.4

1.3

1.65

1.87

u/ml

0.26

358

2736

Corneal ulcer

2486

19696

1.36

34.53

1.4

1.3

1.91

1.74

u/ml

0.20

759

5542

Colectomy operation

1864

14173

1.42

34.52

1.3

2.32

1.77

u/ml

0.56

445

3630

Misadventures to patients during surgical and medical care

1833

13957

1.43

34.49

1.4

1.3

1.24

1.72

u/ml

1.44

453

3813

Eosinophilic disease (BM)

244

1139

2.90

34.34

1.5

1.3

0.59

1.73

u/ml

2.37

323

Conduction disorders

3347

21768

1.29

34.24

1.3

1.82

1.92

u/ml

0.16

856

5480

Other disorders of nervous system

815

5397

1.72

34.20

1.4

1.3

1.71

1.52

u/ml

0.13

196

1421

Pediculosis, acariasis and other infestations, including avohilmo

2696

21705

1.35

33.88

1.5

1.4

1.47

1.73

u/ml

0.55

763

6096

Rash and other nonspecific skin eruption

1290

9373

1.54

33.75

1.4

1.3

2.22

1.87

u/ml

0.29

367

2516

Septicaemia

5080

39260

1.23

33.74

1.4

1.3

1.75

1.80

u/ml

0.09

1289

10165

Other disorders of conjunctiva

1655

12431

1.45

33.74

1.4

1.3

2.07

1.92

u/ml

0.12

441

3298

Presence of other devices

2695

21111

1.32

33.73

1.3

2.10

1.81

u/ml

0.50

667

5318

Scabies, including avohilmo

2370

18836

1.38

33.64

1.5

1.4

1.41

1.69

u/ml

0.57

685

5299

Other peripheral vertigo

1141

8117

1.57

33.38

1.3

1.50

1.69

u/ml

0.24

256

2161

Hypertrophy of breast

2644

21327

1.35

33.37

1.4

1.3

1.09

1.58

u/ml

2.23

825

6172

Speech therapy

3181

25967

1.30

33.35

1.4

1.3

1.54

1.76

u/ml

0.56

685

7019

Acne vulgaris

1570

11913

1.50

33.13

1.5

1.4

1.87

1.84

u/ml

0.04

493

3329

Testicular dysfunction

488

2865

1.99

33.06

1.3

1.93

1.97

u/ml

0.02

158

838

Anosmia

303

1451

2.39

33.02

1.4

1.2

1.62

2.33

u/ml

0.51

392

Transplanted organ and tissue status

1220

8808

1.54

32.71

1.5

1.4

1.82

2.21

u/ml

0.32

310

2295

Other endocrine disorders

884

5879

1.73

32.60

1.7

1.6

0.94

2.23

u/ml

4.92

226

1378

Primary gonarthrosis, bilateral

5989

43177

1.20

32.46

1.3

1.48

1.69

u/ml

0.61

1486

11122

Hepatic failure, not elsewhere classified

472

2784

2.01

32.13

1.4

1.3

3.24

1.64

u/ml

0.64

101

761

ILD, hospital admissions

1546

11550

1.44

31.85

1.3

1.19

1.72

u/ml

1.91

391

2903

Fall on and from stairs and steps

3454

28587

1.28

31.77

1.4

1.3

2.31

1.72

u/ml

0.94

720

7840

AV-block

1797

11630

1.39

31.75

1.3

1.67

1.81

u/ml

0.24

448

2800

Nontoxic multinodular goitre

2356

18731

1.35

31.55

1.3

1.05

1.52

u/ml

2.37

664

4788

Superficial injury of shoulder and upper arm

1627

12353

1.44

31.54

1.4

1.3

1.93

1.79

u/ml

0.12

402

3380

Other and unspecified drugs and medicaments

1144

8260

1.55

31.35

1.5

1.3

1.95

1.47

u/ml

0.37

295

2240

Other interstitial pulmonary diseases

1559

11690

1.43

31.27

1.3

1.21

1.72

u/ml

1.84

397

2935

Injury of muscle and tendon at shoulder and upper arm level

3982

33339

1.25

31.25

1.3

1.42

1.80

u/ml

1.31

1081

8980

Interstitial lung disease endpoints

1559

11692

1.43

31.24

1.3

1.21

1.72

u/ml

1.84

397

2935

Interstitial lung disease

1559

11692

1.43

31.24

1.3

1.21

1.72

u/ml

1.84

397

2935

Ethmoidectomy

1676

12809

1.43

31.22

1.4

1.3

1.55

1.81

u/ml

0.32

472

3645

Testicular hypofunction

436

2526

2.03

31.07

1.3

2.06

1.98

u/ml

0.03

144

747

Nasal polyp

2110

16517

1.36

31.03

1.4

1.3

1.72

1.88

u/ml

0.22

541

4628

Arthropathic psoriasis

1426

10658

1.47

30.93

1.3

1.41

1.73

u/ml

0.41

410

2962

Ptosis of eyelid

1290

9471

1.49

30.70

1.4

1.3

1.21

1.77

u/ml

1.55

270

2447

Emotional disorders starting during childhood or adolescence

1014

7320

1.68

30.59

1.8

1.6

1.82

2.02

u/ml

0.18

237

1829

Thyroiditis

1028

7355

1.60

30.56

1.4

1.3

1.75

1.52

u/ml

0.20

277

2027

Parkinson's disease, strict definition, excluding more controls

1124

7416

1.50

30.54

1.3

1.2

1.42

2.31

u/ml

2.05

278

1796

Other diseases of biliary tract

993

6966

1.57

30.47

1.4

1.3

1.26

1.75

u/ml

1.02

280

1744

conjunctival haemorrhage

902

6239

1.62

30.46

1.4

1.3

2.38

1.59

u/ml

0.53

243

1645

Cluster headache, wide,, including avohilmo

789

5384

1.71

30.37

1.4

1.3

0.95

1.60

u/ml

2.25

242

1579

Flatulence and related conditions

184

809

3.23

30.29

1.4

1.3

0.57

2.27

u/ml

1.65

207

Zoster [herpes zoster]

2218

17573

1.35

30.22

1.3

1.81

1.75

u/ml

0.07

576

4579

Radial styloid tenosynovitis [de Quervain]

827

5674

1.67

30.13

1.4

1.3

0.75

1.72

u/ml

5.65

232

1577

Autism spe, excluding more controls

472

2890

2.06

30.09

1.6

1.5

1.42

1.68

u/ml

0.16

121

778

Diabetic nephropathy, excluding more controls

1819

11457

1.40

30.05

1.7

1.3

2.08

1.49

u/ml

1.19

551

3035

Other benign neoplasms of skin

4640

39570

1.23

29.98

1.3

1.74

1.66

u/ml

0.13

1163

10632

Drug-induced hypoglycaemia without coma

247

1221

2.65

29.97

1.9

1.3

2.24

1.48

u/ml

0.29

336

Unspecified kidney failure

1042

7352

1.53

29.95

1.3

2.07

1.74

u/ml

0.20

211

1851

Calcific tendinitis of shoulder

734

4897

1.70

29.87

1.3

1.35

1.80

u/ml

0.60

261

1332

Nontoxic goitre/thyroid nodule

3699

31022

1.26

29.83

1.3

1.04

1.58

u/ml

5.01

991

8119

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

1086

7813

1.54

29.80

1.4

1.3

1.28

1.64

u/ml

0.59

247

2072

FESS (DNB20)

1619

12412

1.43

29.56

1.4

1.3

1.56

1.83

u/ml

0.31

464

3530

Cluster headache, strict, including avohilmo

756

5150

1.72

29.51

1.4

1.3

0.96

1.60

u/ml

2.06

230

1516

Hyperkalaemia

611

3879

1.75

29.50

1.4

1.3

2.21

1.76

u/ml

0.22

167

989

Other diseases of blood and blood-forming organs, wide

2692

21895

1.31

29.46

1.4

1.3

1.29

1.77

u/ml

2.06

713

5890

Other specified/unspecified soft tissue disorders

595

3788

1.79

29.44

1.5

1.3

0.89

1.66

u/ml

2.66

161

962

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

3852

32397

1.25

29.41

1.4

1.3

1.81

1.75

u/ml

0.09

1085

9088

Anogenital herpesviral [herpes simplex] infection

1064

7749

1.59

29.38

1.4

1.94

1.46

u/ml

0.41

257

2341

ILD, hospital admissions 1, main diag only

1379

10258

1.45

29.38

1.3

1.25

1.66

u/ml

1.19

351

2572

Other respiratory diseases principally affecting the interstitium

1810

13973

1.38

29.35

1.3

1.27

1.78

u/ml

1.91

458

3511

Epilepsy

3780

31573

1.25

29.35

1.4

1.77

1.97

u/ml

0.36

942

8463

Benign neoplasm of other and unspecified endocrine glands

1635

12553

1.42

29.33

1.4

1.3

1.23

1.74

u/ml

1.26

427

3408

Other predominantly sexually transmitted diseases, not elsewhere classified

2704

22168

1.32

29.26

1.4

1.3

1.59

1.55

u/ml

0.05

678

6721

Anankastic personality disorder

635

4197

1.83

29.24

1.5

1.3

1.20

1.38

u/ml

0.19

165

1234

Implicit fungal Sepsis

507

3133

1.90

29.10

1.5

1.3

2.27

1.67

u/ml

0.28

111

827

Parkinson's disease, excluding more controls

1202

7980

1.47

29.05

1.3

1.2

1.81

2.33

u/ml

0.57

305

1926

Fungal Sepsis

541

3396

1.85

29.03

1.5

1.3

2.21

1.60

u/ml

0.32

120

899

419

2525

2.14

28.95

1.5

1.3

0.93

1.86

u/ml

1.54

177

710

Retinal detachments and breaks

3888

32691

1.24

28.94

1.3

2.02

1.73

u/ml

0.45

928

8501

Cardiodefibrillation

3418

28292

1.26

28.86

1.3

1.81

1.84

u/ml

0.04

944

7007

Cramp and spasm

663

4400

1.76

28.82

1.4

1.3

1.20

1.47

u/ml

0.33

172

1221

Acute and subacute iridocyclitis

2378

19132

1.33

28.80

1.4

1.3

1.50

1.76

u/ml

0.58

735

5282

Alopecia areata

460

2840

2.05

28.78

1.6

1.4

2.12

1.88

u/ml

0.09

139

752

Spontaneous rupture of synovium and tendon

939

6594

1.57

28.64

1.3

1.61

2.03

u/ml

0.56

244

1708

Other blood glucose lowering drugs, excl. Insulins

1639

12558

1.39

28.41

1.3

1.53

1.88

u/ml

0.61

422

3182

Fitting and adjustment of other devices

4125

30700

1.23

28.19

1.3

1.64

1.77

u/ml

0.32

1209

7876

Thiazolidinediones

1150

8377

1.49

28.16

1.3

1.25

2.01

u/ml

2.03

319

2150

Sleep disorders, other/unspecified

601

3958

1.83

27.97

1.6

1.4

1.10

1.54

u/ml

0.70

141

1101

Nonsuppurative otitis media

3902

28750

1.25

27.93

1.5

1.4

2.09

1.74

u/ml

0.56

993

8006

Purpura and other haemorrhagic conditions

1664

12879

1.40

27.87

1.4

1.3

2.71

1.87

u/ml

1.11

439

3382

Methotrexate

1770

13811

1.38

27.78

1.3

1.16

1.74

u/ml

2.11

531

3746

Macular pucker

1640

12628

1.39

27.75

1.4

1.3

1.65

1.83

u/ml

0.19

401

3127

Unspecified privation

1339

10079

1.45

27.60

1.4

1.3

1.10

1.65

u/ml

1.85

239

2746

Other disorders of breast

2059

16510

1.37

27.55

1.4

1.3

1.17

1.54

u/ml

0.99

526

4683

Sacrococcygeal disorders, not elsewhere classified

459

2826

1.95

27.47

1.5

1.3

1.76

1.67

u/ml

0.05

116

795

Other (seronegative) rheumatoid arthritis, wide

2263

18205

1.33

27.45

1.3

1.33

1.66

u/ml

0.77

572

4843

Osteomyelitis

717

4829

1.66

27.30

1.5

1.3

1.47

1.92

u/ml

0.60

192

1248

Vasomotor rhinitis (mode)

943

6750

1.57

27.28

1.4

1.3

1.92

1.55

u/ml

0.28

283

1845

All pneumoniae

15441

92137

1.12

27.26

1.4

1.3

1.79

1.66

u/ml

0.51

3986

25846

Pneumonias (Asthma/COPD co-morbidities)

15337

91981

1.12

27.21

1.4

1.3

1.78

1.66

u/ml

0.46

3949

25803

Sacroiliitis, not elsewhere classified

725

4963

1.69

27.11

1.4

1.3

0.78

1.62

u/ml

3.26

214

1451

Postprocedural disorders of digestive system, not elsewhere classified

429

2593

1.97

27.01

1.4

1.3

1.12

1.27

u/ml

0.19

128

687

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Tissue transglutaminase IgA Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS